| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HBS1L ABCA3 GBP7 ABCA12 BMS1 ABCB1 MDN1 ATP11B GBP4 DNAH8 GNL1 DNAH9 EFL1 DNAH3 ARL16 NSF ABCB5 WRN ABCC5 CCT4 EIF2S3B MSH2 GTPBP1 TRAP1 DNAH12 EIF2S3 RAB7B MACF1 DDX53 SEPTIN7 SNRNP200 ATP2B4 DNAH11 | 1.80e-11 | 775 | 217 | 33 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HBS1L ABCA3 GBP7 ABCA12 BMS1 ABCB1 MDN1 ATP11B GBP4 DNAH8 GNL1 DNAH9 EFL1 DNAH3 ARL16 NSF ABCB5 WRN ABCC5 CCT4 EIF2S3B MSH2 GTPBP1 TRAP1 DNAH12 EIF2S3 RAB7B MACF1 DDX53 SEPTIN7 SNRNP200 ATP2B4 DNAH11 | 1.44e-10 | 839 | 217 | 33 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HBS1L ABCA3 GBP7 ABCA12 BMS1 ABCB1 MDN1 ATP11B GBP4 DNAH8 GNL1 DNAH9 EFL1 DNAH3 ARL16 NSF ABCB5 WRN ABCC5 CCT4 EIF2S3B MSH2 GTPBP1 TRAP1 DNAH12 EIF2S3 RAB7B MACF1 DDX53 SEPTIN7 SNRNP200 ATP2B4 DNAH11 | 1.48e-10 | 840 | 217 | 33 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HBS1L ABCA3 GBP7 ABCA12 BMS1 ABCB1 MDN1 ATP11B GBP4 DNAH8 GNL1 DNAH9 EFL1 DNAH3 ARL16 NSF ABCB5 WRN ABCC5 CCT4 EIF2S3B MSH2 GTPBP1 TRAP1 DNAH12 EIF2S3 RAB7B MACF1 DDX53 SEPTIN7 SNRNP200 ATP2B4 DNAH11 | 1.48e-10 | 840 | 217 | 33 | GO:0016818 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.67e-10 | 18 | 217 | 7 | GO:0008569 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 1.36e-08 | 4 | 217 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 1.36e-08 | 4 | 217 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 1.36e-08 | 4 | 217 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.58e-08 | 28 | 217 | 7 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 ABCA12 ABCB1 MDN1 ATP11B DNAH8 DNAH9 DNAH3 NSF ABCB5 WRN ABCC5 CCT4 MSH2 TRAP1 DNAH12 MACF1 DDX53 SNRNP200 ATP2B4 DNAH11 | 1.64e-08 | 441 | 217 | 21 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 ABCA12 DNAH14 ABCB1 MDN1 ATP11B DNAH8 DNAH9 DNAH3 NSF ABCB5 WRN ABCC5 CCT4 MSH2 TRAP1 DNAH12 DNAH17 MYO1F MACF1 DDX53 SNRNP200 ATP2B4 DNAH11 | 6.48e-08 | 614 | 217 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 6.73e-08 | 5 | 217 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 6.73e-08 | 5 | 217 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 6.73e-08 | 5 | 217 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 6.73e-08 | 5 | 217 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 6.73e-08 | 5 | 217 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 6.73e-08 | 5 | 217 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 6.73e-08 | 5 | 217 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.27e-07 | 37 | 217 | 7 | GO:0045505 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 2.00e-07 | 6 | 217 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 4.63e-07 | 7 | 217 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 9.18e-07 | 8 | 217 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 9.18e-07 | 8 | 217 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 9.18e-07 | 8 | 217 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.60e-06 | 34 | 217 | 6 | GO:0042910 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.64e-06 | 9 | 217 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.64e-06 | 9 | 217 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | bile acid binding | 2.71e-06 | 10 | 217 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 2.71e-06 | 10 | 217 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN11A ABCA3 ABCA12 AKR1C4 SLC7A11 RYR3 ABCB1 PTK2B KCNU1 CLCN4 ATP11B SLC44A5 SCN5A PKD1 SCN10A SLC38A11 ABCB5 SLC34A2 ABCC5 GRID1 TTYH3 SLC47A2 SLC7A9 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 NIPAL1 KCNIP4 ATP2B4 | 4.61e-06 | 1180 | 217 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | GTP binding | HBS1L GBP7 GIMAP2 BMS1 GBP4 EIF2B2 GNL1 MOCS1 EFL1 ARL16 EIF2S3B GTPBP1 TGM2 EIF2S3 RAB7B SEPTIN7 | 7.63e-06 | 397 | 217 | 16 | GO:0005525 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.09e-05 | 70 | 217 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.25e-05 | 14 | 217 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.25e-05 | 14 | 217 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 1.69e-05 | 15 | 217 | 4 | GO:0008559 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA3 ABCA12 SLC7A11 ABCB1 CLCN4 SLC44A5 ABCB5 SLC34A2 ABCC5 SLC47A2 SLC7A9 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 ATP2B4 | 1.95e-05 | 477 | 217 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | SCN11A ABCA3 ABCA12 AKR1C4 SLC7A11 RYR3 ABCB1 PTK2B KCNU1 CLCN4 ATP11B SLC44A5 SCN5A PKD1 SCN10A SLC38A11 ABCB5 SLC34A2 ABCC5 GRID1 TTYH3 SLC47A2 SLC7A9 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 NIPAL1 KCNIP4 ATP2B4 | 2.63e-05 | 1289 | 217 | 31 | GO:0005215 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | HBS1L GBP7 GIMAP2 BMS1 GBP4 EIF2B2 GNL1 MOCS1 EFL1 ARL16 EIF2S3B GTPBP1 TGM2 EIF2S3 RAB7B SEPTIN7 | 2.63e-05 | 439 | 217 | 16 | GO:0019001 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | HBS1L GBP7 GIMAP2 BMS1 GBP4 EIF2B2 GNL1 MOCS1 EFL1 ARL16 EIF2S3B GTPBP1 TGM2 EIF2S3 RAB7B SEPTIN7 | 2.63e-05 | 439 | 217 | 16 | GO:0032561 |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.68e-05 | 33 | 217 | 5 | GO:0072349 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 2.89e-05 | 17 | 217 | 4 | GO:0042813 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 3.12e-05 | 34 | 217 | 5 | GO:0016628 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 4.29e-05 | 7 | 217 | 3 | GO:0008467 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.49e-05 | 118 | 217 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 5.73e-05 | 20 | 217 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 1.18e-04 | 2 | 217 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.22e-04 | 24 | 217 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.68e-04 | 26 | 217 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.68e-04 | 26 | 217 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.69e-04 | 48 | 217 | 5 | GO:0016620 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.87e-04 | 49 | 217 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.96e-04 | 27 | 217 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.96e-04 | 11 | 217 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.26e-04 | 28 | 217 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 2.59e-04 | 12 | 217 | 3 | GO:0005436 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.98e-04 | 30 | 217 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 3.29e-04 | 85 | 217 | 6 | GO:0008135 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 3.52e-04 | 56 | 217 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | cadherin binding | FXYD5 ITGA6 PROM1 EPS15L1 FASN NEO1 KDR USO1 EIF2S3 MACF1 SEPTIN7 HDLBP | 3.54e-04 | 339 | 217 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | GTPase activity | HBS1L GBP7 BMS1 GBP4 GNL1 EFL1 ARL16 EIF2S3B GTPBP1 EIF2S3 RAB7B SEPTIN7 | 3.73e-04 | 341 | 217 | 12 | GO:0003924 |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.84e-04 | 32 | 217 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC7A11 CLCN4 SLC44A5 SLC34A2 SLC47A2 SLC7A9 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 | 4.14e-04 | 296 | 217 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.22e-04 | 14 | 217 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.34e-04 | 33 | 217 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 5.23e-04 | 15 | 217 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 5.66e-04 | 62 | 217 | 5 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 5.66e-04 | 62 | 217 | 5 | GO:0050661 | |
| GeneOntologyMolecularFunction | steroid binding | 6.36e-04 | 133 | 217 | 7 | GO:0005496 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 6.39e-04 | 16 | 217 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | amino-acid betaine transmembrane transporter activity | 6.95e-04 | 4 | 217 | 2 | GO:0015199 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 6.95e-04 | 4 | 217 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | flippase activity | 7.69e-04 | 17 | 217 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 8.28e-04 | 39 | 217 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FXYD5 ITGA6 PROM1 EPS15L1 FASN NEO1 SYK KDR UTRN CNTN4 TNC USO1 EIF2S3 MACF1 SEPTIN7 HDLBP | 8.90e-04 | 599 | 217 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 9.12e-04 | 40 | 217 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 9.16e-04 | 18 | 217 | 3 | GO:0030169 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN11A RYR3 PTK2B KCNU1 CLCN4 ATP11B SCN5A PKD1 SCN10A SLC34A2 GRID1 TTYH3 SLC47A2 SLC10A2 SLC20A1 SLC20A2 NIPAL1 KCNIP4 ATP2B4 | 1.10e-03 | 793 | 217 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.23e-03 | 109 | 217 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 1.26e-03 | 20 | 217 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.41e-03 | 112 | 217 | 6 | GO:0090079 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN11A RYR3 PTK2B KCNU1 CLCN4 SCN5A PKD1 SCN10A SLC34A2 ABCC5 TTYH3 SLC47A2 SLC10A2 SLC20A1 SLC20A2 NIPAL1 KCNIP4 ATP2B4 | 1.63e-03 | 758 | 217 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 1.71e-03 | 6 | 217 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 1.71e-03 | 6 | 217 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A RYR3 KCNU1 SCN5A PKD1 SCN10A SLC34A2 SLC10A2 SLC20A1 SLC20A2 NIPAL1 KCNIP4 ATP2B4 | 1.80e-03 | 465 | 217 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 2.16e-03 | 24 | 217 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 2.16e-03 | 24 | 217 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.27e-03 | 51 | 217 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 2.28e-03 | 123 | 217 | 6 | GO:0030165 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 2.38e-03 | 7 | 217 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor binding | 2.38e-03 | 7 | 217 | 2 | GO:0034190 | |
| GeneOntologyMolecularFunction | MutLalpha complex binding | 2.38e-03 | 7 | 217 | 2 | GO:0032405 | |
| GeneOntologyMolecularFunction | syntaxin binding | 2.60e-03 | 87 | 217 | 5 | GO:0019905 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.67e-03 | 127 | 217 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.71e-03 | 171 | 217 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.74e-03 | 26 | 217 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 3.20e-03 | 56 | 217 | 4 | GO:0016830 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB3 TSPAN12 ERBB2 HLA-DPA1 HLA-DRA NPSR1 ADGRB2 SSTR2 PGR SORCS1 FZD1 PTK2B OR51B5 MS4A2 FZD5 PKD1 KDR OR51H1 TAPT1 OR9I1 GRID1 OR8U3 OR10J1 LEPR TGFBR1 OR51V1 | 3.35e-03 | 1353 | 217 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A RYR3 PTK2B KCNU1 SCN5A PKD1 SCN10A SLC34A2 SLC47A2 SLC10A2 SLC20A1 SLC20A2 NIPAL1 KCNIP4 ATP2B4 | 3.67e-03 | 627 | 217 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | SNARE binding | 3.75e-03 | 136 | 217 | 6 | GO:0000149 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 3.93e-03 | 337 | 217 | 10 | GO:0031625 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 2.48e-09 | 7 | 216 | 5 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 2.48e-09 | 7 | 216 | 5 | GO:0071799 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.17e-08 | 4 | 216 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.17e-08 | 4 | 216 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.17e-08 | 4 | 216 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.17e-08 | 4 | 216 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 5.80e-08 | 5 | 216 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 5.80e-08 | 5 | 216 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 5.80e-08 | 5 | 216 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 5.80e-08 | 5 | 216 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 5.80e-08 | 5 | 216 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 5.80e-08 | 5 | 216 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.73e-07 | 6 | 216 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.73e-07 | 6 | 216 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 3.99e-07 | 7 | 216 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN11A FXYD5 SCN5A SCN10A SLC38A11 UTRN PCSK9 SLC34A2 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 ATP2B4 | 1.31e-06 | 275 | 216 | 14 | GO:0006814 |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.41e-06 | 9 | 216 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.84e-06 | 36 | 216 | 6 | GO:0034694 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 2.34e-06 | 10 | 216 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 2.34e-06 | 10 | 216 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 2.34e-06 | 10 | 216 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 2.34e-06 | 10 | 216 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 2.34e-06 | 10 | 216 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 3.47e-06 | 23 | 216 | 5 | GO:0071379 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 3.64e-06 | 11 | 216 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 3.64e-06 | 11 | 216 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 4.69e-06 | 64 | 216 | 7 | GO:0042908 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 1.08e-05 | 14 | 216 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 1.08e-05 | 14 | 216 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 1.46e-05 | 15 | 216 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.93e-05 | 16 | 216 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.93e-05 | 16 | 216 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 3.19e-05 | 18 | 216 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 3.48e-05 | 36 | 216 | 5 | GO:0008299 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 4.17e-05 | 89 | 216 | 7 | GO:2000379 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 6.09e-05 | 21 | 216 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 6.09e-05 | 21 | 216 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 6.09e-05 | 21 | 216 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 6.09e-05 | 21 | 216 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 6.09e-05 | 21 | 216 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SCN11A FXYD5 SCN5A SCN10A UTRN PCSK9 SLC34A2 SLC20A1 SLC20A2 ATP2B4 | 7.13e-05 | 208 | 216 | 10 | GO:0035725 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 7.21e-05 | 67 | 216 | 6 | GO:0019748 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 7.38e-05 | 22 | 216 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 7.38e-05 | 22 | 216 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | parturition | 7.38e-05 | 22 | 216 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 7.38e-05 | 22 | 216 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | BBS1 DNAH14 DNAH8 DNAH9 DNAH3 DNAI3 DNAH12 DNAH17 ATP2B4 DNAH11 | 7.73e-05 | 210 | 216 | 10 | GO:0060294 |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 8.86e-05 | 23 | 216 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 9.37e-05 | 44 | 216 | 5 | GO:0072337 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | BBS1 DNAH14 DNAH8 DNAH9 DNAH3 DNAI3 DNAH12 DNAH17 ATP2B4 DNAH11 | 9.39e-05 | 215 | 216 | 10 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | BBS1 DNAH14 DNAH8 DNAH9 DNAH3 DNAI3 DNAH12 DNAH17 ATP2B4 DNAH11 | 9.39e-05 | 215 | 216 | 10 | GO:0001539 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN11A NPSR1 FXYD5 RYR3 ABCB1 PTK2B KCNU1 MS4A2 CLCN4 ATP11B SCN5A PKD1 SCN10A SLC38A11 UTRN PCSK9 NSF SLC34A2 ABCC5 GRID1 TTYH3 SLC47A2 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 NIPAL1 KCNIP4 ATP2B4 | 1.06e-04 | 1374 | 216 | 30 | GO:0006811 |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A NPSR1 FXYD5 RYR3 PTK2B KCNU1 MS4A2 SCN5A PKD1 SCN10A SLC38A11 UTRN PCSK9 NSF SLC34A2 ABCC5 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 NIPAL1 KCNIP4 ATP2B4 | 1.37e-04 | 1000 | 216 | 24 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.46e-04 | 26 | 216 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | AKR1C4 AKR1C1 AKR1C2 FASN SYK ALDH18A1 OAT LIPC MALRD1 AKR1C3 PNPLA8 ACMSD ATP2B4 | 1.68e-04 | 374 | 216 | 13 | GO:0046394 |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 1.79e-04 | 149 | 216 | 8 | GO:0062014 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | AKR1C4 AKR1C1 AKR1C2 FASN SYK ALDH18A1 OAT LIPC MALRD1 AKR1C3 PNPLA8 ACMSD ATP2B4 | 1.82e-04 | 377 | 216 | 13 | GO:0016053 |
| GeneOntologyBiologicalProcess | glutamine family amino acid metabolic process | 1.94e-04 | 80 | 216 | 6 | GO:0009064 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.97e-04 | 28 | 216 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | xenobiotic export from cell | 2.26e-04 | 29 | 216 | 4 | GO:0046618 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 2.26e-04 | 29 | 216 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 2.26e-04 | 29 | 216 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN11A NPSR1 FXYD5 RYR3 ABCB1 PTK2B KCNU1 MS4A2 CLCN4 ATP11B SCN5A PKD1 SCN10A UTRN PCSK9 SLC34A2 ABCC5 GRID1 TTYH3 SLC47A2 SLC20A1 SLC20A2 NIPAL1 KCNIP4 ATP2B4 | 2.80e-04 | 1115 | 216 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 2.98e-04 | 56 | 216 | 5 | GO:0006693 | |
| GeneOntologyBiologicalProcess | carnitine metabolic process | 3.00e-04 | 13 | 216 | 3 | GO:0009437 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 3.03e-04 | 161 | 216 | 8 | GO:0051592 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 3.23e-04 | 57 | 216 | 5 | GO:0006692 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 3.26e-04 | 88 | 216 | 6 | GO:0071277 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 3.34e-04 | 32 | 216 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | tube development | EPHB3 TSPAN12 ERBB2 ABCA3 ABCA12 IFT172 DZIP1L ADGRB2 SLC7A11 PGR STAB1 FZD1 PHEX PTK2B PROM1 FZD5 PKD1 SYK KDR C5 HS3ST3B1 HS3ST3A1 TNC CNMD ATXN1L LEPR TGFBR1 TGM2 ATP2B4 | 3.45e-04 | 1402 | 216 | 29 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 3.51e-04 | 58 | 216 | 5 | GO:0032350 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TSPAN12 ABCA12 IFT172 BBS1 ITGA6 PGR FZD1 FANCD2 PHEX PROM1 PIM1 FZD5 SCN5A PKD1 SCN10A SYK KDR HS3ST3B1 HS3ST3A1 AGTPBP1 WHRN TMEM176B TNC TGFBR1 TGM2 PAX4 DNAH11 | 3.63e-04 | 1269 | 216 | 27 | GO:0009887 |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 3.77e-04 | 33 | 216 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | AKR1C4 SLC7A11 AKR1C1 ABCB1 SYK SLC38A11 DPYSL2 ABCC5 TTYH3 SLC7A9 ACE2 SLC10A2 PNPLA8 | 4.08e-04 | 410 | 216 | 13 | GO:0046942 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 4.24e-04 | 34 | 216 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | organic acid transport | AKR1C4 SLC7A11 AKR1C1 ABCB1 SYK SLC38A11 DPYSL2 ABCC5 TTYH3 SLC7A9 ACE2 SLC10A2 PNPLA8 | 4.27e-04 | 412 | 216 | 13 | GO:0015849 |
| GeneOntologyBiologicalProcess | cilium movement | BBS1 DNAH14 DNAH8 DNAH9 DNAH3 DNAI3 DNAH12 DNAH17 ATP2B4 DNAH11 | 4.48e-04 | 261 | 216 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 4.75e-04 | 35 | 216 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 4.75e-04 | 35 | 216 | 4 | GO:0015012 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A NPSR1 FXYD5 RYR3 PTK2B KCNU1 MS4A2 SCN5A PKD1 SCN10A SLC38A11 UTRN PCSK9 NSF SLC34A2 ABCC5 SLC47A2 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 NIPAL1 KCNIP4 ATP2B4 | 4.84e-04 | 1157 | 216 | 25 | GO:0006812 |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 6.53e-04 | 38 | 216 | 4 | GO:0048384 | |
| GeneOntologyBiologicalProcess | glutamate metabolic process | 6.53e-04 | 38 | 216 | 4 | GO:0006536 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan metabolic process | 6.91e-04 | 17 | 216 | 3 | GO:0030201 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 7.24e-04 | 141 | 216 | 7 | GO:0034341 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB3 ERBB2 HLA-DPA1 ABCA12 HLA-DRA FXYD5 ITGA6 VIT LAPTM5 PTK2B PKD1 SYK KDR UTRN TBCD TNC CBFB TGM2 BRD7 MYO1F MACF1 | 7.67e-04 | 927 | 216 | 21 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transport | 7.84e-04 | 69 | 216 | 5 | GO:1902305 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 7.96e-04 | 40 | 216 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | regulation of amino acid metabolic process | 8.23e-04 | 18 | 216 | 3 | GO:0006521 | |
| GeneOntologyBiologicalProcess | amino-acid betaine metabolic process | 8.23e-04 | 18 | 216 | 3 | GO:0006577 | |
| GeneOntologyBiologicalProcess | regulation of reactive oxygen species metabolic process | 8.45e-04 | 188 | 216 | 8 | GO:2000377 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 8.75e-04 | 189 | 216 | 8 | GO:0010565 | |
| GeneOntologyBiologicalProcess | lipid transport | ABCA3 ABCA12 AKR1C4 AKR1C1 ABCB1 ATP11B SYK PDZD8 PCSK9 LBP LIPC SLC10A2 PNPLA8 HDLBP | 9.41e-04 | 506 | 216 | 14 | GO:0006869 |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 9.59e-04 | 42 | 216 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | SCN11A ABCA12 STXBP2 MS4A2 SYT11 SYK SYT3 STXBP5L PRRT2 MYO1F | 1.03e-03 | 291 | 216 | 10 | GO:0045055 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN11A NPSR1 FXYD5 RYR3 PTK2B KCNU1 MS4A2 CLCN4 SCN5A PKD1 SCN10A UTRN PCSK9 SLC34A2 ABCC5 TTYH3 SLC47A2 SLC20A1 SLC20A2 NIPAL1 KCNIP4 ATP2B4 | 1.05e-03 | 1017 | 216 | 22 | GO:0098660 |
| GeneOntologyBiologicalProcess | citrulline biosynthetic process | 1.07e-03 | 5 | 216 | 2 | GO:0019240 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 1.08e-03 | 74 | 216 | 5 | GO:2000351 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid metabolic process | 1.12e-03 | 111 | 216 | 6 | GO:0043648 | |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 1.13e-03 | 20 | 216 | 3 | GO:0044406 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 1.14e-03 | 75 | 216 | 5 | GO:0048286 | |
| GeneOntologyCellularComponent | dynein complex | 8.48e-08 | 54 | 218 | 8 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.80e-07 | 25 | 218 | 6 | GO:0005858 | |
| GeneOntologyCellularComponent | axoneme | IFT172 DZIP1L BBS1 DNAH8 DNAH9 DNAH3 INPP5E DNAI3 DNAH12 DNAH17 SEPTIN7 DNAH11 | 1.92e-06 | 207 | 218 | 12 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | IFT172 DZIP1L BBS1 DNAH8 DNAH9 DNAH3 INPP5E DNAI3 DNAH12 DNAH17 SEPTIN7 DNAH11 | 2.02e-06 | 208 | 218 | 12 | GO:0097014 |
| GeneOntologyCellularComponent | apical plasma membrane | ERBB2 MPDZ ABCB1 PROM1 STXBP2 SLC34A2 ABCC5 SI SLC47A2 SLC7A9 TGFBR1 ACE2 SLC10A2 SLC20A2 SLC22A4 SLC22A5 SEPTIN7 CEACAM20 | 3.85e-06 | 487 | 218 | 18 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | ERBB2 MPDZ SLC7A11 ABCB1 PROM1 STXBP2 SLC34A2 ABCC5 SI SLC47A2 SLC7A9 TGFBR1 ACE2 SLC10A2 SLC20A2 SLC22A4 SLC22A5 SEPTIN7 CEACAM20 | 1.54e-05 | 592 | 218 | 19 | GO:0045177 |
| GeneOntologyCellularComponent | motile cilium | PRAMEF10 IFT172 BBS1 DNAH14 KCNU1 PKD1 DNAH8 DNAH9 DNAH3 DNAH12 DNAH17 SEPTIN7 ATP2B4 DNAH11 | 2.33e-05 | 355 | 218 | 14 | GO:0031514 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | IFT172 DZIP1L BBS1 DNAH8 DNAH9 AGTPBP1 DNAH3 INPP5E DNAI3 DNAH12 DNAH17 SEPTIN7 DNAH11 | 3.05e-05 | 317 | 218 | 13 | GO:0032838 |
| GeneOntologyCellularComponent | actin-based cell projection | ERBB2 ITGA6 SLC7A11 PROM1 UTRN MPP1 WHRN SLC34A2 LIPC SLC10A2 MYO1F CEACAM20 | 3.77e-05 | 278 | 218 | 12 | GO:0098858 |
| GeneOntologyCellularComponent | 9+2 motile cilium | IFT172 DNAH14 KCNU1 DNAH8 DNAH9 DNAH3 DNAH12 DNAH17 SEPTIN7 ATP2B4 DNAH11 | 4.29e-05 | 238 | 218 | 11 | GO:0097729 |
| GeneOntologyCellularComponent | microvillus | 4.53e-05 | 123 | 218 | 8 | GO:0005902 | |
| GeneOntologyCellularComponent | cilium | PRAMEF10 IFT172 DZIP1L BBS1 DNAH14 PROM1 KCNU1 CLCN4 PKD1 DNAH8 DNAH9 WHRN DNAH3 TAPT1 INPP5E CCT4 DNAI3 ACE2 DNAH12 DNAH17 SEPTIN7 ATP2B4 DNAH11 | 6.86e-05 | 898 | 218 | 23 | GO:0005929 |
| GeneOntologyCellularComponent | cytoplasmic region | IFT172 DZIP1L BBS1 DNAH8 DNAH9 AGTPBP1 DNAH3 INPP5E DNAI3 DNAH12 DNAH17 SEPTIN7 DNAH11 | 1.11e-04 | 360 | 218 | 13 | GO:0099568 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | SLC7A11 PROM1 MPP1 WHRN SLC34A2 SI SLC7A9 ACE2 SLC20A2 SLC22A5 | 1.23e-04 | 223 | 218 | 10 | GO:0098862 |
| GeneOntologyCellularComponent | inner dynein arm | 1.27e-04 | 10 | 218 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | brush border | 1.99e-04 | 152 | 218 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | outer dynein arm | 2.30e-04 | 12 | 218 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | brush border membrane | 2.32e-04 | 83 | 218 | 6 | GO:0031526 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.95e-04 | 161 | 218 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | cell projection membrane | ERBB2 BBS1 SLC7A11 PROM1 PKD1 UTRN SLC34A2 SLC7A9 ACE2 SLC20A2 SLC22A5 MACF1 CEACAM20 | 6.27e-04 | 431 | 218 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | lamellar body membrane | 6.41e-04 | 4 | 218 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | C-fiber | 6.41e-04 | 4 | 218 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | microvillus membrane | 6.43e-04 | 38 | 218 | 4 | GO:0031528 | |
| GeneOntologyCellularComponent | interstitial matrix | 6.83e-04 | 17 | 218 | 3 | GO:0005614 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.83e-04 | 17 | 218 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 1.06e-03 | 5 | 218 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | SCN11A ERBB2 HLA-DPA1 HLA-DRA ITGA6 MPDZ PTK2B EPS15L1 NEO1 MS4A2 SCN5A SCN10A SYK C5 UTRN TGFBR1 KCNIP4 TRAV27 | 1.53e-03 | 785 | 218 | 18 | GO:0098797 |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 2 complex | 1.58e-03 | 6 | 218 | 2 | GO:0005850 | |
| GeneOntologyCellularComponent | host intracellular region | 1.58e-03 | 6 | 218 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 1.58e-03 | 6 | 218 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 1.58e-03 | 6 | 218 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 1.58e-03 | 6 | 218 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 1.58e-03 | 6 | 218 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 1.58e-03 | 6 | 218 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 1.58e-03 | 6 | 218 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 1.94e-03 | 215 | 218 | 8 | GO:0030662 | |
| GeneOntologyCellularComponent | distal axon | SCN11A PGR PTK2B NEO1 SYT11 WHRN MAPK8IP1 DPYSL2 PRRT2 ARPC5 TANC1 SEPTIN7 | 2.14e-03 | 435 | 218 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | postsynapse | RPL22 ERBB2 CTTNBP2 MPDZ PGR PTK2B NEO1 PIAS3 SYT11 EIF2B2 UTRN WHRN DPYSL2 SYT3 NSF GRID1 PRRT2 MACF1 TANC1 RPL35 SEPTIN7 | 2.31e-03 | 1018 | 218 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | presynapse | RPL22 SCN11A ERBB2 CTTNBP2 PGR PTK2B EPS15L1 STXBP2 CLCN4 PIAS3 SYT11 SCN10A WHRN DPYSL2 PRRT2 TANC1 RPL35 SEPTIN7 ATP2B4 | 2.43e-03 | 886 | 218 | 19 | GO:0098793 |
| GeneOntologyCellularComponent | clathrin coat | 2.77e-03 | 56 | 218 | 4 | GO:0030118 | |
| GeneOntologyCellularComponent | male pronucleus | 2.91e-03 | 8 | 218 | 2 | GO:0001940 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.35e-03 | 29 | 218 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | junctional membrane complex | 3.71e-03 | 9 | 218 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 3.76e-03 | 293 | 218 | 9 | GO:0030658 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 3.77e-03 | 61 | 218 | 4 | GO:0030660 | |
| GeneOntologyCellularComponent | basal plasma membrane | ERBB2 FXYD5 ITGA6 PKD1 ABCC5 LEPR TGFBR1 SLC22A4 SLC22A5 ATP2B4 | 4.16e-03 | 354 | 218 | 10 | GO:0009925 |
| MousePheno | parturition failure | 4.19e-06 | 10 | 170 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 6.52e-06 | 11 | 170 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 1.39e-05 | 13 | 170 | 4 | MP:0010160 | |
| MousePheno | decreased vocalization | 1.85e-05 | 46 | 170 | 6 | MP:0020351 | |
| MousePheno | increased circulating progesterone level | 2.60e-05 | 15 | 170 | 4 | MP:0005186 | |
| MousePheno | long stride length | 2.60e-05 | 15 | 170 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 2.60e-05 | 15 | 170 | 4 | MP:0002293 | |
| MousePheno | increased stereotypic behavior | 4.23e-05 | 53 | 170 | 6 | MP:0001409 | |
| MousePheno | abnormal gestational length | 5.66e-05 | 18 | 170 | 4 | MP:0002292 | |
| MousePheno | abnormal diestrus | 6.06e-05 | 35 | 170 | 5 | MP:0009010 | |
| MousePheno | dysmyelination | 8.79e-05 | 20 | 170 | 4 | MP:0013438 | |
| MousePheno | blood vessel congestion | 1.35e-04 | 65 | 170 | 6 | MP:0000255 | |
| MousePheno | visceral vascular congestion | 1.48e-04 | 42 | 170 | 5 | MP:0010017 | |
| MousePheno | abnormal vocalization | CTTNBP2 AKR1C4 AKR1C1 AKR1C2 EPS15L1 UTP20 NSF SI SLC20A2 AKR1C3 MVD | 1.53e-04 | 237 | 170 | 11 | MP:0001529 |
| MousePheno | pulmonary vascular congestion | 1.86e-04 | 24 | 170 | 4 | MP:0010018 | |
| MousePheno | decreased oligodendrocyte number | 2.19e-04 | 25 | 170 | 4 | MP:0009808 | |
| Domain | - | HBS1L ABCA3 GBP7 ABCA12 GIMAP2 BMS1 DNAH14 ABCB1 MDN1 GBP4 HS3ST4 HS3ST3B1 HS3ST3A1 DNAH8 GNL1 DNAH9 MPP1 EFL1 DNAH3 NWD1 ARL16 NSF ABCB5 WRN ABCC5 MSH2 GTPBP1 DNAH12 EIF2S3 MYO1F RAB7B DDX53 SEPTIN7 SNRNP200 DNAH11 | 8.31e-13 | 746 | 212 | 35 | 3.40.50.300 |
| Domain | P-loop_NTPase | HBS1L ABCA3 GBP7 ABCA12 GIMAP2 BMS1 DNAH14 ABCB1 MDN1 GBP4 HS3ST4 HS3ST3B1 HS3ST3A1 DNAH8 GNL1 DNAH9 MPP1 EFL1 DNAH3 NWD1 ARL16 NSF ABCB5 WRN ABCC5 MSH2 GTPBP1 DNAH12 EIF2S3 MYO1F RAB7B DDX53 SEPTIN7 SNRNP200 DNAH11 | 3.06e-11 | 848 | 212 | 35 | IPR027417 |
| Domain | Dynein_heavy_chain_D4_dom | 5.55e-09 | 14 | 212 | 6 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 5.55e-09 | 14 | 212 | 6 | IPR011704 | |
| Domain | AAA_8 | 5.55e-09 | 14 | 212 | 6 | PF12780 | |
| Domain | AAA_5 | 5.55e-09 | 14 | 212 | 6 | PF07728 | |
| Domain | DHC_fam | 9.16e-09 | 15 | 212 | 6 | IPR026983 | |
| Domain | Dynein_heavy | 9.16e-09 | 15 | 212 | 6 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.16e-09 | 15 | 212 | 6 | IPR004273 | |
| Domain | AAA | ABCA3 ABCA12 ABCB1 MDN1 DNAH8 DNAH9 DNAH3 NSF ABCB5 ABCC5 DNAH12 SNRNP200 DNAH11 | 1.02e-08 | 144 | 212 | 13 | SM00382 |
| Domain | AAA+_ATPase | ABCA3 ABCA12 ABCB1 MDN1 DNAH8 DNAH9 DNAH3 NSF ABCB5 ABCC5 DNAH12 SNRNP200 DNAH11 | 1.02e-08 | 144 | 212 | 13 | IPR003593 |
| Domain | Dynein_HC_stalk | 3.31e-07 | 14 | 212 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.31e-07 | 14 | 212 | 5 | IPR013602 | |
| Domain | DHC_N2 | 3.31e-07 | 14 | 212 | 5 | PF08393 | |
| Domain | MT | 3.31e-07 | 14 | 212 | 5 | PF12777 | |
| Domain | TF_GTP-bd_dom | 1.84e-06 | 19 | 212 | 5 | IPR000795 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.21e-06 | 10 | 212 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.21e-06 | 10 | 212 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.21e-06 | 10 | 212 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 3.21e-06 | 10 | 212 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.21e-06 | 10 | 212 | 4 | IPR020471 | |
| Domain | - | 2.64e-05 | 16 | 212 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 3.42e-05 | 17 | 212 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 3.42e-05 | 17 | 212 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 3.42e-05 | 17 | 212 | 4 | IPR001395 | |
| Domain | EFTu-like_2 | 4.36e-05 | 18 | 212 | 4 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 4.36e-05 | 18 | 212 | 4 | PF03144 | |
| Domain | G_TR_2 | 4.36e-05 | 18 | 212 | 4 | PS51722 | |
| Domain | DHC_N1 | 7.74e-05 | 8 | 212 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.74e-05 | 8 | 212 | 3 | IPR013594 | |
| Domain | ABC_transporter_CS | 1.09e-04 | 42 | 212 | 5 | IPR017871 | |
| Domain | Phos_transporter | 1.28e-04 | 2 | 212 | 2 | IPR001204 | |
| Domain | PHO4 | 1.28e-04 | 2 | 212 | 2 | PF01384 | |
| Domain | Na_channel_asu | 1.63e-04 | 10 | 212 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.63e-04 | 10 | 212 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.63e-04 | 10 | 212 | 3 | PF06512 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 1.63e-04 | 10 | 212 | 3 | IPR009001 | |
| Domain | ABC_tran | 2.07e-04 | 48 | 212 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.07e-04 | 48 | 212 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.28e-04 | 49 | 212 | 5 | PS00211 | |
| Domain | Transl_B-barrel | 2.31e-04 | 27 | 212 | 4 | IPR009000 | |
| Domain | ABC_transporter-like | 2.51e-04 | 50 | 212 | 5 | IPR003439 | |
| Domain | Recoverin | 3.79e-04 | 13 | 212 | 3 | IPR028846 | |
| Domain | KH_1 | 8.80e-04 | 38 | 212 | 4 | PF00013 | |
| Domain | - | 9.72e-04 | 39 | 212 | 4 | 3.30.1370.10 | |
| Domain | KH | 1.07e-03 | 40 | 212 | 4 | SM00322 | |
| Domain | KH_dom | 1.07e-03 | 40 | 212 | 4 | IPR004087 | |
| Domain | C1-set_C | 1.25e-03 | 5 | 212 | 2 | PF16196 | |
| Domain | MHC_II_alpha | 1.25e-03 | 5 | 212 | 2 | SM00920 | |
| Domain | C1-set_C | 1.25e-03 | 5 | 212 | 2 | IPR032431 | |
| Domain | KH_TYPE_1 | 1.29e-03 | 42 | 212 | 4 | PS50084 | |
| Domain | KH_dom_type_1 | 1.54e-03 | 44 | 212 | 4 | IPR004088 | |
| Domain | ARM-type_fold | CAND1 IFT172 RYR3 URB1 UTP20 AGTPBP1 TBCD API5 WDFY4 RIF1 USO1 | 1.76e-03 | 339 | 212 | 11 | IPR016024 |
| Domain | Methyltransf_12 | 1.87e-03 | 6 | 212 | 2 | IPR013217 | |
| Domain | MHC_II_alpha | 1.87e-03 | 6 | 212 | 2 | PF00993 | |
| Domain | Methyltransf_12 | 1.87e-03 | 6 | 212 | 2 | PF08242 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 7.49e-07 | 27 | 173 | 6 | M47755 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA3 CAND1 ABCA12 SLC7A11 RYR3 ABCB1 CLCN4 ATP11B SLC44A5 PCSK9 ABCB5 SLC34A2 ABCC5 EIF2S3B TTYH3 SLC7A9 LIPC SLC20A1 SLC20A2 EIF2S3 SLC22A4 SLC22A5 NIPAL1 ATP2B4 HDLBP | 8.73e-07 | 681 | 173 | 25 | MM14985 |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 2.63e-06 | 9 | 173 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 2.63e-06 | 9 | 173 | 4 | M47817 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA3 CAND1 ABCA12 SLC7A11 RYR3 ABCB1 CLCN4 ATP11B SLC44A5 PCSK9 ABCB5 SLC34A2 ABCC5 TTYH3 SLC47A2 SLC7A9 LIPC SLC20A1 SLC20A2 EIF2S3 SLC22A4 SLC22A5 NIPAL1 ATP2B4 HDLBP | 3.53e-06 | 736 | 173 | 25 | M27287 |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 6.76e-06 | 11 | 173 | 4 | M47812 | |
| Pathway | REACTOME_PREDNISONE_ADME | 7.39e-06 | 23 | 173 | 5 | MM16639 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.31e-05 | 43 | 173 | 6 | M47669 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.44e-05 | 13 | 173 | 4 | MM14747 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.44e-05 | 13 | 173 | 4 | M17842 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.72e-05 | 45 | 173 | 6 | M47670 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 1.78e-05 | 5 | 173 | 3 | M27345 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 1.78e-05 | 5 | 173 | 3 | MM15085 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.99e-05 | 14 | 173 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.99e-05 | 14 | 173 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.99e-05 | 14 | 173 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.99e-05 | 14 | 173 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 2.69e-05 | 15 | 173 | 4 | MM14870 | |
| Pathway | REACTOME_RECYCLING_OF_EIF2_GDP | 1.45e-04 | 9 | 173 | 3 | MM15418 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.62e-04 | 23 | 173 | 4 | MM14741 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.62e-04 | 23 | 173 | 4 | M1926 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.94e-04 | 44 | 173 | 5 | M499 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.94e-04 | 44 | 173 | 5 | M11911 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.14e-04 | 99 | 173 | 7 | MM14986 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 2.16e-04 | 45 | 173 | 5 | MM14751 | |
| Pathway | BIOCARTA_VEGF_PATHWAY | 3.08e-04 | 27 | 173 | 4 | M12975 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.56e-04 | 28 | 173 | 4 | MM15188 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 6.15e-04 | 85 | 173 | 6 | M48315 | |
| Pathway | REACTOME_DRUG_ADME | 6.57e-04 | 119 | 173 | 7 | MM15692 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.79e-04 | 33 | 173 | 4 | MM14737 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 6.79e-04 | 33 | 173 | 4 | M5967 | |
| Pubmed | 2.01e-10 | 7 | 220 | 5 | 22529366 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 2.01e-10 | 7 | 220 | 5 | 34843575 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CAND1 STAB1 FANCD2 GMPS FASN MDN1 FYTTD1 NSF CCT4 MSH2 API5 GTPBP1 RIF1 TRAP1 USO1 BRD7 MACF1 SEPTIN7 SNRNP200 HDLBP | 1.15e-09 | 582 | 220 | 20 | 20467437 |
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 10393440 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 1.56e-09 | 4 | 220 | 4 | 31479646 | |
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 10702227 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 17442338 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 28329705 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 16511129 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 15222881 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 10526179 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 21521174 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 8274401 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 1.56e-09 | 4 | 220 | 4 | 34590152 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 1.56e-09 | 4 | 220 | 4 | 10500239 | |
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 1.56e-09 | 4 | 220 | 4 | 14967952 | |
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 1.56e-09 | 4 | 220 | 4 | 15193432 | |
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 16191478 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 15577209 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 1.56e-09 | 4 | 220 | 4 | 29764944 | |
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 17888864 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 19237748 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 28259989 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 7789999 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 1.56e-09 | 4 | 220 | 4 | 16508162 | |
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 17629694 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 16018803 | ||
| Pubmed | 1.56e-09 | 4 | 220 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 1.56e-09 | 4 | 220 | 4 | 18667791 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL22 HBS1L CAND1 BMS1 FANCD2 FASN URB1 MDN1 WDR75 PIM1 ALDH18A1 UTP20 CLUH NSF OAT CCT4 MSH2 API5 GTPBP1 RIF1 TRAP1 USO1 EIF2S3 H1-0 SLTM PNPLA8 MPHOSPH8 RPL35 SEPTIN7 SNRNP200 HDLBP | 2.18e-09 | 1425 | 220 | 31 | 30948266 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL22 HBS1L CAND1 ME1 BIRC6 FANCD2 GMPS EPS15L1 FASN PAPOLA EIF2B2 GNL1 CLUH TBCD EFL1 DPYSL2 BAG5 CCT4 MSH2 API5 ARPC5 TGM2 TRAP1 GTF2F2 EIF2S3 MACF1 RPL35 SEPTIN7 SNRNP200 MVD HDLBP | 3.56e-09 | 1455 | 220 | 31 | 22863883 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EPHB3 ERBB2 TMEM199 ITGA6 FANCD2 NEO1 MDN1 HPCAL1 C5 DPY19L2 TAPT1 NSF BAG5 OAT TTYH3 SLC47A2 TGFBR1 RIF1 GTF2F2 USO1 SLC20A1 EIF2S3 SLC22A5 MACF1 SEPTIN7 ATP2B4 | 4.43e-09 | 1061 | 220 | 26 | 33845483 |
| Pubmed | 7.75e-09 | 5 | 220 | 4 | 7737980 | ||
| Pubmed | 7.75e-09 | 5 | 220 | 4 | 38788959 | ||
| Pubmed | 7.75e-09 | 5 | 220 | 4 | 18003893 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 7.75e-09 | 5 | 220 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 7.75e-09 | 5 | 220 | 4 | 16984997 | |
| Pubmed | 7.75e-09 | 5 | 220 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 7.75e-09 | 5 | 220 | 4 | 17064890 | |
| Pubmed | 7.75e-09 | 5 | 220 | 4 | 10672042 | ||
| Pubmed | BMS1 BIRC6 GMPS FASN URB1 MDN1 WDR75 ALDH18A1 UTP20 UTRN CLUH DPYSL2 OAT MSH2 RBM28 RIF1 SLTM MACF1 SNRNP200 HDLBP | 8.04e-09 | 653 | 220 | 20 | 22586326 | |
| Pubmed | RPL22 CAND1 CTTNBP2 PTK2B EPS15L1 FASN UTRN AGTPBP1 MAPK8IP1 DPYSL2 SYT3 NSF MTERF1 TNC OAT CCT4 EIF2S3B GTPBP1 ARPC5 USO1 EIF2S3 H1-0 MACF1 TANC1 RPL35 SEPTIN7 SNRNP200 ATP2B4 DNAH11 HDLBP | 9.43e-09 | 1431 | 220 | 30 | 37142655 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPL22 CAND1 ME1 AKR1C1 AKR1C2 FASN MDN1 ALDH18A1 UTRN AP1M2 CCT4 TGM2 TRAP1 EIF2S3 H1-0 SLTM AKR1C3 MACF1 RPL35 SNRNP200 MVD HDLBP | 1.14e-08 | 807 | 220 | 22 | 30575818 |
| Pubmed | 1.20e-08 | 13 | 220 | 5 | 11682476 | ||
| Pubmed | 1.20e-08 | 13 | 220 | 5 | 17062636 | ||
| Pubmed | 1.85e-08 | 14 | 220 | 5 | 9373155 | ||
| Pubmed | 2.31e-08 | 6 | 220 | 4 | 19273550 | ||
| Pubmed | 2.31e-08 | 6 | 220 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 2.31e-08 | 6 | 220 | 4 | 26748576 | |
| Pubmed | 2.31e-08 | 6 | 220 | 4 | 17122075 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 2.31e-08 | 6 | 220 | 4 | 29107092 | |
| Pubmed | 2.31e-08 | 6 | 220 | 4 | 15860270 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 2.31e-08 | 6 | 220 | 4 | 17255200 | |
| Pubmed | HBS1L PRAMEF10 GBP7 DZIP1L AKR1C4 AKR1C1 AKR1C2 URB1 POLR3D GBP4 WDR75 PAPOLA UTRN FYTTD1 INPP5E RALGPS2 RBM28 ATXN1L WDFY4 ARPC5 TGFBR1 SLC20A1 SLTM AKR1C3 MACF1 | 2.93e-08 | 1084 | 220 | 25 | 11544199 | |
| Pubmed | 5.37e-08 | 7 | 220 | 4 | 33127481 | ||
| Pubmed | 5.37e-08 | 7 | 220 | 4 | 12562828 | ||
| Pubmed | 5.37e-08 | 7 | 220 | 4 | 19846565 | ||
| Pubmed | 5.37e-08 | 7 | 220 | 4 | 9256245 | ||
| Pubmed | 5.37e-08 | 7 | 220 | 4 | 26160177 | ||
| Pubmed | 5.37e-08 | 7 | 220 | 4 | 31178125 | ||
| Pubmed | 5.37e-08 | 7 | 220 | 4 | 16337335 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | ERBB2 SSTR2 PGR ABCB1 KDR TNC WRN MSH2 LEPR TGFBR1 ARNT SLC10A2 EXO1 AKR1C3 | 6.33e-08 | 351 | 220 | 14 | 20453000 |
| Pubmed | 1.07e-07 | 8 | 220 | 4 | 20837989 | ||
| Pubmed | 1.07e-07 | 8 | 220 | 4 | 33584538 | ||
| Pubmed | 1.07e-07 | 8 | 220 | 4 | 9224647 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL22 HBS1L CAND1 BMS1 BIRC6 GMPS FASN URB1 MDN1 WDR75 ALDH18A1 UTP20 PRR14L UTRN DPYSL2 CCT4 MSH2 RBM28 TGM2 RIF1 H1-0 SLTM MACF1 TANC1 RPL35 SNRNP200 HDLBP | 1.49e-07 | 1353 | 220 | 27 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL22 CAND1 ABCB1 FASN URB1 MDN1 STXBP2 WDR75 UTP20 UTRN NSF CCT4 MSH2 RBM28 RIF1 TRAP1 SLC20A1 H1-0 SLTM MACF1 RPL35 SNRNP200 HDLBP | 1.74e-07 | 1024 | 220 | 23 | 24711643 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL22 CAND1 BMS1 ITGA6 GMPS EPS15L1 FASN NAA25 ALDH18A1 GNL1 UTRN CLUH TBCD DPYSL2 NSF CCT4 TTYH3 GTPBP1 TGM2 USO1 SLC20A1 H1-0 SLTM RPL35 SEPTIN7 MVD HDLBP | 1.83e-07 | 1367 | 220 | 27 | 32687490 |
| Pubmed | 1.91e-07 | 9 | 220 | 4 | 33348080 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 19320734 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 21232532 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 2.50e-07 | 3 | 220 | 3 | 31780644 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 13678667 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 7626489 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 3.18e-07 | 10 | 220 | 4 | 36313771 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL22 BMS1 FASN URB1 MDN1 WDR75 ALDH18A1 PDZD8 UTP20 FYTTD1 CCT4 MSH2 RBM28 RIF1 TRAP1 TRMT2A EIF2S3 SLTM MPHOSPH8 ISG20L2 RPL35 SNRNP200 | 3.85e-07 | 989 | 220 | 22 | 36424410 |
| Pubmed | RPL22 CAND1 MDN1 UTRN BAG5 CCT4 EIF2S3B API5 ARPC5 RIF1 EIF2S3 SLTM MACF1 RPL35 SEPTIN7 SNRNP200 | 3.92e-07 | 538 | 220 | 16 | 28524877 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL22 CAND1 BMS1 BIRC6 URB1 MDN1 UTP20 AGTPBP1 FYTTD1 WRN MSH2 RBM28 GTPBP1 RIF1 EIF2S3 EXO1 MACF1 ISG20L2 SNRNP200 | 4.35e-07 | 759 | 220 | 19 | 35915203 |
| Pubmed | 4.64e-07 | 25 | 220 | 5 | 26098214 | ||
| Pubmed | 5.17e-07 | 47 | 220 | 6 | 11208732 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HBS1L SCN11A CAND1 HLA-DRA HNMT ABCB1 PROM1 FASN STXBP2 PKD1 SCN10A C5 BBOX1 UTRN ZG16B GRID1 TTYH3 LBP ARPC5 ACE2 TGM2 SLC22A5 | 6.03e-07 | 1016 | 220 | 22 | 19056867 |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 7.41e-07 | 12 | 220 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 7.41e-07 | 12 | 220 | 4 | 28893949 | |
| Pubmed | 7.41e-07 | 12 | 220 | 4 | 25774556 | ||
| Pubmed | CAND1 IFT172 GMPS FASN MDN1 WDR75 NSF BAG5 CCT4 MSH2 API5 RIF1 TRAP1 USO1 EIF2S3 SEPTIN7 SNRNP200 | 7.72e-07 | 638 | 220 | 17 | 33239621 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | GMPS FASN WDR75 FYTTD1 CCT4 RBM28 CBFB RIF1 USO1 BRD7 H1-0 SLTM ISG20L2 | 7.93e-07 | 370 | 220 | 13 | 22922362 |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | ERBB2 AKR1C4 PGR ABCB1 PIM1 WRN MSH2 LEPR TGFBR1 ARNT LIPC EXO1 AKR1C3 | 8.94e-07 | 374 | 220 | 13 | 19625176 |
| Pubmed | HBS1L CAND1 BMS1 MPDZ URB1 MDN1 WDR75 ALDH18A1 UTP20 UTRN TBP TDRKH FYTTD1 NSF WRN CCT4 API5 ARPC5 RIF1 GTF2F2 EIF2S3 BRD7 MACF1 MPHOSPH8 ISG20L2 TANC1 HDLBP | 1.06e-06 | 1497 | 220 | 27 | 31527615 | |
| Pubmed | 1.07e-06 | 13 | 220 | 4 | 24580729 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 1.07e-06 | 13 | 220 | 4 | 15117747 | |
| Pubmed | ERBB2 AKR1C4 PGR ABCB1 PIM1 WRN MSH2 LEPR TGFBR1 ARNT LIPC EXO1 AKR1C3 | 1.10e-06 | 381 | 220 | 13 | 18676680 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL22 HBS1L CAND1 BMS1 GMPS FASN MDN1 STXBP2 WDR75 ALDH18A1 MPP1 NSF WRN OAT CCT4 MSH2 RBM28 GTPBP1 TGM2 TRAP1 TAF3 EIF2S3 H1-0 RPL35 SNRNP200 | 1.12e-06 | 1318 | 220 | 25 | 30463901 |
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | ERBB2 AKR1C4 PGR ABCB1 PIM1 WRN MSH2 LEPR TGFBR1 ARNT LIPC EXO1 AKR1C3 | 1.13e-06 | 382 | 220 | 13 | 19170196 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | BMS1 DGKH BIRC6 DNAH14 CABLES1 GMPS URB1 MDN1 PKD1 ALDH18A1 UTP20 UTRN DNAH3 DPYSL2 RBM28 ATXN1L EBLN1 SNRNP200 | 1.23e-06 | 736 | 220 | 18 | 29676528 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL22 CAND1 MPDZ ME1 GMPS FASN MDN1 STXBP2 DPYSL2 PCBP3 NSF BAG5 CCT4 API5 ARPC5 TRAP1 USO1 EIF2S3 MACF1 RPL35 SEPTIN7 SNRNP200 HDLBP | 1.26e-06 | 1149 | 220 | 23 | 35446349 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | CAND1 GMPS TBCD DPYSL2 PCBP3 NSF MTERF1 CCT4 API5 GTPBP1 TRAP1 TRMT2A USO1 H1-0 SEPTIN7 SNRNP200 HDLBP | 1.36e-06 | 665 | 220 | 17 | 30457570 |
| Interaction | AKR1C4 interactions | 7.76e-07 | 8 | 210 | 4 | int:AKR1C4 | |
| Interaction | AKR1C1 interactions | 1.60e-06 | 20 | 210 | 5 | int:AKR1C1 | |
| Interaction | GGCT interactions | 1.10e-05 | 73 | 210 | 7 | int:GGCT | |
| Interaction | EED interactions | RPL22 CAND1 BIRC6 FANCD2 GMPS PTK2B EPS15L1 FASN URB1 NAA25 STXBP2 ALDH18A1 UTP20 GNL1 CLUH TBCD FYTTD1 NSF CCT4 MSH2 API5 RBM28 ARPC5 RIF1 USO1 EIF2S3 H1-0 SLTM MACF1 ISG20L2 TANC1 SNRNP200 HDLBP | 1.66e-05 | 1445 | 210 | 33 | int:EED |
| Cytoband | 10p15-p14 | 2.15e-06 | 6 | 220 | 3 | 10p15-p14 | |
| Cytoband | 4p15.32 | 5.81e-05 | 16 | 220 | 3 | 4p15.32 | |
| Cytoband | Xp22.2-p22.1 | 2.26e-04 | 5 | 220 | 2 | Xp22.2-p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q31 | 5.96e-04 | 140 | 220 | 5 | chr7q31 | |
| GeneFamily | Dyneins, axonemal | 4.47e-11 | 17 | 151 | 7 | 536 | |
| GeneFamily | Aldo-keto reductases | 5.94e-06 | 15 | 151 | 4 | 399 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.62e-05 | 9 | 151 | 3 | 1203 | |
| GeneFamily | Exonucleases | 2.95e-04 | 16 | 151 | 3 | 544 | |
| GeneFamily | Solute carriers | SLC7A11 SLC44A5 SLC38A11 SLC34A2 SLC47A2 SLC7A9 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 | 4.92e-04 | 395 | 151 | 11 | 752 |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 2.17e-07 | 17 | 218 | 5 | MM826 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.76e-06 | 25 | 218 | 5 | MM480 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 4.86e-06 | 150 | 218 | 9 | MM936 | |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 7.12e-06 | 85 | 218 | 7 | MM802 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.06e-05 | 60 | 218 | 6 | M1401 | |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 1.47e-05 | 172 | 218 | 9 | M2945 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | ABCA3 AKR1C4 AKR1C1 AKR1C2 PTK2B ATP11B HS3ST3B1 HS3ST3A1 ZG16B AKR1C3 | 1.62e-05 | 219 | 218 | 10 | MM1237 |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | RPL22 HLA-DPA1 CEP85L GIMAP2 FXYD5 ABCB1 LAPTM5 PTK2B MS4A2 PIM1 UTRN CCT4 CBFB ARPC5 TGFBR1 MYO1F MACF1 RPL35 SEPTIN7 SNRNP200 ATP2B4 | 2.65e-05 | 911 | 218 | 21 | M40038 |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.86e-05 | 75 | 218 | 6 | MM605 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP | 4.12e-05 | 196 | 218 | 9 | M10014 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 4.28e-05 | 197 | 218 | 9 | M7458 | |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_UP | 4.28e-05 | 197 | 218 | 9 | M9997 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 4.34e-05 | 24 | 218 | 4 | MM766 | |
| Coexpression | IBRAHIM_NRF2_UP | HBS1L ME1 SLC7A11 AKR1C1 AKR1C2 ABCB1 ATP11B PAPOLA FYTTD1 CBFB USO1 BRD7 SLTM AKR1C3 PNPLA8 | 4.41e-05 | 533 | 218 | 15 | M42510 |
| Coexpression | GSE6259_BCELL_VS_CD4_TCELL_DN | HBS1L HLA-DPA1 PROM1 EIF2B2 ALDH18A1 FYTTD1 CBFB SLC7A9 USO1 | 4.46e-05 | 198 | 218 | 9 | M6733 |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | AKR1C4 GCKR AKR1C1 AKR1C2 C5 BBOX1 CLUH PCSK9 LBP SLC7A9 LIPC AKR1C3 NIPAL1 MVD HDLBP | 4.60e-05 | 535 | 218 | 15 | MM3635 |
| Coexpression | GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | TSPAN12 SLC7A11 PGR STXBP2 ATP11B TTYH3 TGM2 TMEM132E CEACAM20 | 4.82e-05 | 200 | 218 | 9 | M8693 |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | 4.82e-05 | 200 | 218 | 9 | M5068 | |
| Coexpression | GSE39864_WT_VS_GATA3_KO_TREG_UP | 4.82e-05 | 200 | 218 | 9 | M9064 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP | 4.82e-05 | 200 | 218 | 9 | M4347 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HLA-DPA1 CEP85L GIMAP2 FXYD5 BIRC6 MYSM1 ABCB1 LAPTM5 PTK2B MS4A2 ATP11B PAPOLA PIM1 UTRN TBCD FYTTD1 CCT4 CBFB ARPC5 TGFBR1 RIF1 SLC20A1 MYO1F MACF1 MPHOSPH8 SEPTIN7 SNRNP200 ATP2B4 | 4.93e-05 | 1492 | 218 | 28 | M40023 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 5.18e-05 | 79 | 218 | 6 | MM535 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | HLA-DPA1 HLA-DRA ITGA6 HNMT AKR1C1 ABCB1 LAPTM5 STAB1 PROM1 ATP11B HPCAL1 PIM1 FZD5 SYK UTRN SLC34A2 TTYH3 ARPC5 TGM2 SLC20A1 EIF2S3 AKR1C3 MACF1 TANC1 ATP2B4 | 6.54e-05 | 1276 | 218 | 25 | M39173 |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_UP | TSPAN12 HLA-DPA1 GIMAP2 HLA-DRA HNMT AKR1C1 LAPTM5 PAPOLA UTRN LEPR ACE2 TGM2 EIF2S3 | 7.00e-05 | 430 | 218 | 13 | M3654 |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 8.57e-05 | 168 | 218 | 8 | M1124 | |
| Coexpression | TRAVAGLINI_LUNG_MUCOUS_CELL | 8.69e-05 | 125 | 218 | 7 | M41656 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | AKR1C4 AKR1C1 AKR1C2 ABCB1 LAPTM5 COL14A1 DPYSL2 ABCC5 EIF2S3B ATXN1L ARPC5 ARNT EIF2S3 SLTM AKR1C3 | 8.98e-05 | 568 | 218 | 15 | MM3824 |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 9.49e-05 | 88 | 218 | 6 | M5360 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | RPL22 HLA-DPA1 HLA-DRA BMS1 SLC7A11 LAPTM5 URB1 POLR3D MS4A2 ATP11B PAPOLA SYK TBP MTERF1 INPP5E CCT4 MSH2 CBFB ARPC5 TGFBR1 RIF1 GTF2F2 ARNT EIF2S3 ISG20L2 PAX4 | 1.03e-04 | 1394 | 218 | 26 | M9585 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | HBS1L SCN11A FXYD5 SSTR2 LAPTM5 STAB1 PTK2B STXBP2 HPCAL1 FZD5 SYK ALDH18A1 COL14A1 C5 MTERF1 TNC CNMD ABCC5 CBFB WDFY4 ARPC5 LIPC MYO1F RAB7B TANC1 | 1.06e-04 | 1316 | 218 | 25 | MM1052 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.08e-04 | 30 | 218 | 4 | MM853 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | HBS1L SCN11A FXYD5 SSTR2 LAPTM5 STAB1 PTK2B STXBP2 HPCAL1 FZD5 SYK ALDH18A1 COL14A1 C5 TNC CNMD ABCC5 CBFB WDFY4 ARPC5 LIPC MYO1F RAB7B TANC1 | 1.14e-04 | 1242 | 218 | 24 | M1920 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | TSPAN12 PRAMEF10 TMEM199 ITGA6 AKR1C4 AKR1C1 AKR1C2 PGR PROM1 STXBP2 SYK MPP1 FYTTD1 SYT3 INPP5E LBP CBFB MYO1F AKR1C3 | 1.33e-04 | 871 | 218 | 19 | MM1005 |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.41e-04 | 135 | 218 | 7 | M5825 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.49e-04 | 182 | 218 | 8 | MM993 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_DN | 1.61e-04 | 138 | 218 | 7 | MM1151 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_MYELOID | 1.69e-04 | 139 | 218 | 7 | M39044 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | CAND1 PRAMEF10 FZD1 PAPOLA PIM1 FZD5 UTRN FYTTD1 TNC RBM28 TGFBR1 ARNT ISG20L2 HDLBP | 1.97e-04 | 543 | 218 | 14 | MM997 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | CTTNBP2 ADGRB2 DGKH RYR3 CABLES1 HS3ST4 EIF2S3B TTYH3 LBP TMEM132E EIF2S3 RAB7B | 2.05e-04 | 416 | 218 | 12 | MM1002 |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP | 2.14e-04 | 102 | 218 | 6 | M6681 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 2.14e-04 | 102 | 218 | 6 | MM872 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 2.23e-04 | 36 | 218 | 4 | MM3660 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 2.25e-04 | 66 | 218 | 5 | MM631 | |
| Coexpression | BMI1_DN_MEL18_DN.V1_DN | 2.38e-04 | 147 | 218 | 7 | M2775 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 2.48e-04 | 37 | 218 | 4 | MM630 | |
| Coexpression | GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP | 2.56e-04 | 197 | 218 | 8 | M4167 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN | 2.65e-04 | 198 | 218 | 8 | M9234 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_DN | 2.74e-04 | 199 | 218 | 8 | M5182 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.74e-04 | 199 | 218 | 8 | M5257 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 2.74e-04 | 199 | 218 | 8 | M9236 | |
| Coexpression | HUANG_FOXA2_TARGETS_DN | 2.75e-04 | 38 | 218 | 4 | M16701 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 2.77e-04 | 69 | 218 | 5 | MM621 | |
| Coexpression | LE_EGR2_TARGETS_DN | 2.78e-04 | 107 | 218 | 6 | M15148 | |
| Coexpression | GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP | 2.83e-04 | 200 | 218 | 8 | M5819 | |
| Coexpression | GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN | 2.83e-04 | 200 | 218 | 8 | M8552 | |
| Coexpression | GSE17580_TREG_VS_TEFF_UP | 2.83e-04 | 200 | 218 | 8 | M3670 | |
| Coexpression | GSE30083_SP1_VS_SP4_THYMOCYTE_DN | 2.83e-04 | 200 | 218 | 8 | M5030 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP | 2.83e-04 | 200 | 218 | 8 | M6558 | |
| Coexpression | GSE17721_12H_VS_24H_POLYIC_BMDC_DN | 2.83e-04 | 200 | 218 | 8 | M4102 | |
| Coexpression | GSE7764_NKCELL_VS_SPLENOCYTE_UP | 2.83e-04 | 200 | 218 | 8 | M5720 | |
| Coexpression | GSE7852_TREG_VS_TCONV_FAT_DN | 2.83e-04 | 200 | 218 | 8 | M5735 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CTTNBP2 ITGA6 PROM1 NEO1 WDR75 PDZD8 PRR14L RIF1 SLC20A2 BRD7 MPHOSPH8 SNRNP200 | 3.01e-04 | 434 | 218 | 12 | M15150 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | NCALD HLA-DPA1 HLA-DRA LAPTM5 MS4A2 FZD5 UTP20 DPYSL2 TGFBR1 AKR1C3 MACF1 | 3.05e-04 | 372 | 218 | 11 | M19261 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | RPL22 NCALD ITGA6 ANKRD36C ABCB1 NEO1 MDN1 ALDH18A1 HS3ST3B1 AGTPBP1 RALGPS2 ABCC5 MSH2 EIF2S3 AKR1C3 MACF1 RPL35 SNRNP200 ATP2B4 TRAV27 | 3.24e-04 | 1012 | 218 | 20 | M40864 |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | HLA-DPA1 ABCA12 PLCXD2 ITGA6 MPDZ AKR1C1 PGR EPS15L1 ATP11B PIAS3 KDR UTRN ZG16B LEPR TGM2 AKR1C3 MACF1 | 3.33e-04 | 786 | 218 | 17 | M10961 |
| Coexpression | DESCARTES_FETAL_LIVER_HEPATOBLASTS | PLCXD2 TMEM199 AKR1C2 KCNU1 C5 SLC38A11 BBOX1 PCSK9 LBP ACE2 LIPC AKR1C3 ACMSD | 3.38e-04 | 505 | 218 | 13 | M40234 |
| Coexpression | INGRAM_SHH_TARGETS_UP | 3.42e-04 | 156 | 218 | 7 | MM550 | |
| Coexpression | MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN | 3.57e-04 | 207 | 218 | 8 | M38977 | |
| Coexpression | MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN | 3.83e-04 | 159 | 218 | 7 | M38979 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 3.84e-04 | 74 | 218 | 5 | MM769 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 3.93e-04 | 210 | 218 | 8 | MM958 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 3.99e-04 | 323 | 218 | 10 | M9150 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CTTNBP2 ITGA6 PROM1 NEO1 WDR75 PDZD8 PRR14L RIF1 SLC20A2 BRD7 MPHOSPH8 SNRNP200 | 4.01e-04 | 448 | 218 | 12 | MM1044 |
| Coexpression | HOOI_ST7_TARGETS_DN | 4.09e-04 | 115 | 218 | 6 | M14801 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | CAND1 FZD1 PAPOLA PIM1 FZD5 UTRN FYTTD1 TNC RBM28 TGFBR1 ARNT ISG20L2 HDLBP | 4.37e-04 | 519 | 218 | 13 | M3395 |
| Coexpression | E2F3_UP.V1_DN | 4.45e-04 | 163 | 218 | 7 | M2704 | |
| Coexpression | LE_EGR2_TARGETS_DN | 4.49e-04 | 117 | 218 | 6 | MM1139 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | RPL22 CAND1 GBP7 GMPS CLUH TDRKH FYTTD1 CCT4 LBP RBM28 CBFB WDFY4 | 4.87e-04 | 458 | 218 | 12 | M1606 |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | ABCA3 CTTNBP2 ABCB1 LAPTM5 STAB1 MS4A2 SYT11 SLC38A11 MPP1 DPYSL2 EIF2S3B | 1.00e-09 | 172 | 219 | 11 | c477008444d2d71071177807870d7455e90c2fad |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-08 | 184 | 219 | 10 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-08 | 186 | 219 | 10 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-08 | 187 | 219 | 10 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | TSPAN12 NCALD SSTR2 SLC38A11 MOCS1 CNTN4 GRID1 PRRT2 SEPTIN7 DNAH11 | 3.58e-08 | 189 | 219 | 10 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PHEX COL14A1 HS3ST3A1 CNTN4 PCBP3 TNC RALGPS2 GRID1 DNAI3 SPIDR | 3.77e-08 | 190 | 219 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | CTTNBP2 HLA-DRA ME1 STAB1 FZD1 SYT11 TMEM176B ABCC5 TTYH3 RPL35 | 4.58e-08 | 194 | 219 | 10 | 11ff53a748160570d2908ea9eb9779c038e5b676 |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | HLA-DRA ME1 LAPTM5 STAB1 KCNU1 MPP1 TMEM176B ABCC5 TTYH3 MYO1F | 4.58e-08 | 194 | 219 | 10 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SCN11A HLA-DPA1 HLA-DRA SLC7A11 SYK HS3ST3B1 WDFY4 MYO1F RAB7B | 1.35e-07 | 165 | 219 | 9 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-07 | 169 | 219 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-07 | 176 | 219 | 9 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-07 | 177 | 219 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | HLA-DPA1 HLA-DRA SLC7A11 SYK HS3ST3B1 WDFY4 SLC20A1 MYO1F RAB7B | 2.45e-07 | 177 | 219 | 9 | c5e829bc4594761666d65cace5a9c5d19c16f187 |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-07 | 190 | 219 | 9 | d541e076137cf7334bdb0ed69db2f9a27c668c65 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-07 | 191 | 219 | 9 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 5.08e-07 | 193 | 219 | 9 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Monocytes-C1QA+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.31e-07 | 194 | 219 | 9 | 3e104e85574894c04791252d466d438fc809dde3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-07 | 194 | 219 | 9 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-07 | 194 | 219 | 9 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-07 | 194 | 219 | 9 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.54e-07 | 195 | 219 | 9 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.54e-07 | 195 | 219 | 9 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-07 | 197 | 219 | 9 | b17ac6c88dc53e54e04e8a79409d9a0de0be88dc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-07 | 197 | 219 | 9 | a9f8edeef73a5261d7661dd1987aaa5bf6183af8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-07 | 197 | 219 | 9 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-07 | 197 | 219 | 9 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-07 | 197 | 219 | 9 | a22c0f2ffac34635c9c8221aee778e2fc78d672b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-07 | 197 | 219 | 9 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ERBB2 ANKRD36C AKR1C1 AKR1C2 PROM1 BBOX1 SLC34A2 TGM2 AKR1C3 | 6.30e-07 | 198 | 219 | 9 | 829377071f65016d31d09175a43c28e95532b404 |
| ToppCell | C_01|World / shred on cell type and cluster | 6.30e-07 | 198 | 219 | 9 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ERBB2 ANKRD36C AKR1C1 AKR1C2 PROM1 BBOX1 SLC34A2 TGM2 AKR1C3 | 6.30e-07 | 198 | 219 | 9 | 27a3c1c5ac855dff8d63f44eaa289be3f5bd621a |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 6.30e-07 | 198 | 219 | 9 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-07 | 198 | 219 | 9 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-07 | 199 | 219 | 9 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | proximal-Epithelial-Mucous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.57e-07 | 199 | 219 | 9 | baac580484124b7c36717b607adcf2cb446e631d | |
| ToppCell | proximal-Epithelial-Mucous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.57e-07 | 199 | 219 | 9 | 15ba36fa6ad73d0e959e42f18d7acbc14e310dc9 | |
| ToppCell | 3'-Parenchyma_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA3 HLA-DPA1 HLA-DRA FXYD5 LAPTM5 STXBP2 HPCAL1 DPYSL2 ARPC5 | 6.57e-07 | 199 | 219 | 9 | bc064ccfec8c1e96079b89b05aeebddf48bc87f3 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CTTNBP2 HLA-DPA1 HLA-DRA LAPTM5 STAB1 UTRN TTYH3 WDFY4 MYO1F | 6.57e-07 | 199 | 219 | 9 | f34c15df58fbdc6c90e30800e26fabbf828ad10b |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-07 | 199 | 219 | 9 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-07 | 199 | 219 | 9 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.57e-07 | 199 | 219 | 9 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-07 | 199 | 219 | 9 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | proximal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.57e-07 | 199 | 219 | 9 | 3018378860de084662be0cc46fce421db3bb9ec9 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 6.57e-07 | 199 | 219 | 9 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.85e-07 | 200 | 219 | 9 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | mLN-B_cell-Follicular_B_cell|B_cell / Region, Cell class and subclass | RPL22 HLA-DPA1 HLA-DRA ABCB1 LAPTM5 CLCN4 SLC38A11 TAPT1 RPL35 | 6.85e-07 | 200 | 219 | 9 | 8fbd27ffcfd0702ad3c340d32455e36a01617139 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.85e-07 | 200 | 219 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-07 | 200 | 219 | 9 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.89e-06 | 168 | 219 | 8 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-06 | 169 | 219 | 8 | da3485d77bb7876fad4f166f6099e681b27457ae | |
| ToppCell | (5)_Dendritic_cell-(51)_cDC1|(5)_Dendritic_cell / shred on Cell_type and subtype | 2.59e-06 | 123 | 219 | 7 | d46cfdf8b3e561d8db33903207d5151cdb2a91d4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-06 | 178 | 219 | 8 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-06 | 180 | 219 | 8 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-06 | 182 | 219 | 8 | d22ab50b135482915687c70e6dad29bfe2bb2c68 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 183 | 219 | 8 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-06 | 183 | 219 | 8 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.72e-06 | 184 | 219 | 8 | 315bb14e848d8e8e4533122047df6f9b89b89d99 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.72e-06 | 184 | 219 | 8 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 3.87e-06 | 185 | 219 | 8 | 23ffba9216729b5bdb30b35742ba2627bb1200bf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.94e-06 | 131 | 219 | 7 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.03e-06 | 186 | 219 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-06 | 187 | 219 | 8 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_DC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-06 | 188 | 219 | 8 | 08eb1e4b719af53c52895557523d0a1b7421d849 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 188 | 219 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-06 | 189 | 219 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-06 | 189 | 219 | 8 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-06 | 189 | 219 | 8 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.53e-06 | 189 | 219 | 8 | 0a490730cdc912d5233de59057550de0e4065747 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.71e-06 | 190 | 219 | 8 | 441770ce7b3c81f36f5b15b8e51794f736462457 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.71e-06 | 190 | 219 | 8 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.71e-06 | 190 | 219 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.90e-06 | 191 | 219 | 8 | 51535232e889db52a9b24e5696b1687e93dd7302 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.90e-06 | 191 | 219 | 8 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | 3'_v3-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 4.90e-06 | 191 | 219 | 8 | 44a797b39254cbfa5c2bad8155436adfd3019bb0 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 4.90e-06 | 191 | 219 | 8 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-06 | 192 | 219 | 8 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 5.09e-06 | 192 | 219 | 8 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.09e-06 | 192 | 219 | 8 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.09e-06 | 192 | 219 | 8 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.29e-06 | 193 | 219 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.29e-06 | 193 | 219 | 8 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.29e-06 | 193 | 219 | 8 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 5.29e-06 | 193 | 219 | 8 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 194 | 219 | 8 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.49e-06 | 194 | 219 | 8 | b700381f8337b4c6aa50d09ab5bfcd59f2fb2cf3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.49e-06 | 194 | 219 | 8 | 84aa5ca0356a06fce8799eb1bfa1c362bab34032 | |
| ToppCell | B_cell_maturation-Naive_B_cell|B_cell_maturation / Lineage and Cell class | 5.49e-06 | 194 | 219 | 8 | adb6f9aff65276e0db1f8367149998938b8e4fb0 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 194 | 219 | 8 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.70e-06 | 195 | 219 | 8 | ee8743d39996bb756f50db32748e8a902d3294b8 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.70e-06 | 195 | 219 | 8 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.70e-06 | 195 | 219 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.70e-06 | 195 | 219 | 8 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Naive_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-06 | 195 | 219 | 8 | f00e6d000e107daed68d3ffa8948e1f6a41eb242 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.70e-06 | 195 | 219 | 8 | 9231e929657542b78a6480d44402866511129c7f | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 5.92e-06 | 196 | 219 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.92e-06 | 196 | 219 | 8 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Monocyte-derived_DC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.92e-06 | 196 | 219 | 8 | 6d056d8336df6b31065be6f7b041bf553fe7c521 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.92e-06 | 196 | 219 | 8 | 7ce416e1809bfbb39553c28c20125790100a938d | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.92e-06 | 196 | 219 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.92e-06 | 196 | 219 | 8 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| Drug | flunisolide | 1.07e-09 | 13 | 215 | 6 | ctd:C007734 | |
| Drug | cloxazolam | 7.73e-09 | 4 | 215 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 7.73e-09 | 4 | 215 | 4 | ctd:D011278 | |
| Drug | tetralol | 7.73e-09 | 4 | 215 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 7.73e-09 | 4 | 215 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 3.84e-08 | 5 | 215 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 3.84e-08 | 5 | 215 | 4 | ctd:C010092 | |
| Drug | Medazepam | 1.14e-07 | 6 | 215 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 5.25e-07 | 8 | 215 | 4 | ctd:D009567 | |
| Drug | tetrofosmin | 7.48e-07 | 19 | 215 | 5 | CID000004274 | |
| Drug | cyclopentanol | 8.30e-07 | 3 | 215 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 8.30e-07 | 3 | 215 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 8.30e-07 | 3 | 215 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 8.30e-07 | 3 | 215 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 8.30e-07 | 3 | 215 | 3 | ctd:C530610 | |
| Drug | 4-hydroxybenzoic acid | 9.39e-07 | 9 | 215 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 9.39e-07 | 9 | 215 | 4 | ctd:D004092 | |
| Drug | benzo(a)pyrene-7,8-dione | 9.90e-07 | 20 | 215 | 5 | ctd:C076588 | |
| Drug | benzbromarone | 1.20e-06 | 37 | 215 | 6 | CID000002333 | |
| Drug | octyl gallate | 1.55e-06 | 10 | 215 | 4 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 2.42e-06 | 11 | 215 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 2.42e-06 | 11 | 215 | 4 | CID000013946 | |
| Drug | tetrahydrodeoxycorticosterone | 3.30e-06 | 4 | 215 | 3 | ctd:C009413 | |
| Drug | 9-methylphenazine-1-carboxylic acid | 3.30e-06 | 4 | 215 | 3 | CID004037810 | |
| Drug | gliquidone | 3.30e-06 | 4 | 215 | 3 | ctd:C010969 | |
| Drug | DBD-H | 3.30e-06 | 4 | 215 | 3 | CID000131382 | |
| Drug | Phenolphthalein | 3.61e-06 | 12 | 215 | 4 | ctd:D020113 | |
| Drug | AC1L45LU | ERBB2 SLC7A11 ABCB1 FANCD2 PTK2B KDR ABCB5 LBP TRAP1 ARNT H1-0 | 4.27e-06 | 205 | 215 | 11 | CID000151069 |
| Drug | Norethindrone | 4.88e-06 | 27 | 215 | 5 | ctd:D009640 | |
| Drug | DMBA-3,4-dihydrodiol | 5.17e-06 | 13 | 215 | 4 | CID000050096 | |
| Drug | Diazepam | 6.39e-06 | 74 | 215 | 7 | ctd:D003975 | |
| Drug | Dydrogesterone | 7.19e-06 | 14 | 215 | 4 | ctd:D004394 | |
| Drug | 5-alpha-Dihydroprogesterone | 7.19e-06 | 14 | 215 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 7.19e-06 | 14 | 215 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 7.19e-06 | 14 | 215 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 8.19e-06 | 5 | 215 | 3 | CID000257630 | |
| Drug | drospirenone | 9.73e-06 | 15 | 215 | 4 | ctd:C035144 | |
| Drug | PAK-104P | 9.73e-06 | 15 | 215 | 4 | CID000131368 | |
| Drug | platinum | TSPAN12 ERBB2 ABCB1 FANCD2 SCN10A ABCC5 CCT4 MSH2 RIF1 TRAP1 | 1.00e-05 | 183 | 215 | 10 | CID000023939 |
| Drug | naringenin | 1.06e-05 | 111 | 215 | 8 | ctd:C005273 | |
| Drug | Budesonide | 1.08e-05 | 80 | 215 | 7 | ctd:D019819 | |
| Drug | sodium | NACA2 ERBB2 SLC7A11 RYR3 PGR GMPS PHEX PTK2B ATP11B SCN5A PKD1 SCN10A HS3ST3A1 NSF SLC34A2 GRID1 CCT4 SLC7A9 SLC10A2 SLC20A1 SLC20A2 SLC22A4 SLC22A5 ATP2B4 | 1.08e-05 | 944 | 215 | 24 | CID000000923 |
| Drug | 17beta-estradiol glucuronide | 1.17e-05 | 32 | 215 | 5 | CID000066424 | |
| Drug | Ursodeoxycholic Acid | HLA-DRA GCKR AKR1C1 AKR1C2 PGR ABCB1 FASN TMEM176B TGM2 ARNT SLC10A2 AKR1C3 | 1.34e-05 | 276 | 215 | 12 | ctd:D014580 |
| Drug | AC1L93E5 | 1.63e-05 | 6 | 215 | 3 | CID000412383 | |
| Drug | AC1L99H3 | 1.63e-05 | 6 | 215 | 3 | CID000440540 | |
| Drug | Estazolam | 1.63e-05 | 6 | 215 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 1.63e-05 | 6 | 215 | 3 | CID000439898 | |
| Drug | Glipizide | 1.63e-05 | 6 | 215 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 1.63e-05 | 6 | 215 | 3 | ctd:C023723 | |
| Drug | orthovanadate | SSTR2 ABCB1 PTK2B SYK DNAH9 DNAH3 NSF TNC ABCB5 ABCC5 ARNT DNAH17 ACMSD ATP2B4 DNAH11 | 1.80e-05 | 435 | 215 | 15 | CID000061672 |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; HL60; HT_HG-U133A | 1.98e-05 | 198 | 215 | 10 | 6145_UP | |
| Drug | Ruthenium Compounds | 2.13e-05 | 18 | 215 | 4 | ctd:D017975 | |
| Drug | probenecid | 2.26e-05 | 123 | 215 | 8 | CID000004911 | |
| Drug | quinocetone | AKR1C1 RYR3 CABLES1 PGR FASN PIM1 STXBP5L DNAH12 KCNIP4 ATP2B4 MVD | 2.56e-05 | 248 | 215 | 11 | ctd:C502851 |
| Drug | oxcarbazepine | 2.68e-05 | 19 | 215 | 4 | ctd:C036006 | |
| Drug | 4-hydroxyequilenin-o-quinone | 2.83e-05 | 7 | 215 | 3 | ctd:C117714 | |
| Drug | zomepirac | 2.83e-05 | 7 | 215 | 3 | ctd:C020549 | |
| Drug | puerarin | 2.87e-05 | 63 | 215 | 6 | CID005281807 | |
| Drug | Chrysenes | 3.33e-05 | 20 | 215 | 4 | ctd:D002911 | |
| Drug | AC1L1IZE | 3.55e-05 | 131 | 215 | 8 | CID000004799 | |
| Drug | 20 alpha-dihydroprogesterone | 3.60e-05 | 40 | 215 | 5 | CID000008956 | |
| Drug | vanadyl | SSTR2 ABCB1 PTK2B SYK DNAH8 DNAH9 DNAH3 NSF WRN DNAH17 ACMSD DNAH11 | 3.81e-05 | 307 | 215 | 12 | CID000061671 |
| Drug | Zidovudine | ABCA3 ME1 PGR ABCB1 FASN GBP4 TNC INPP5E ABCC5 SLC7A9 SLC20A1 SLC20A2 SLC22A4 SLC22A5 MVD HDLBP | 3.87e-05 | 521 | 215 | 16 | ctd:D015215 |
| Drug | Biliton | 4.07e-05 | 41 | 215 | 5 | CID000002974 | |
| Drug | Lactic Acid | 4.07e-05 | 41 | 215 | 5 | ctd:D019344 | |
| Drug | o-quinone | 4.07e-05 | 41 | 215 | 5 | CID000011421 | |
| Drug | Flunitrazepam | 4.08e-05 | 21 | 215 | 4 | ctd:D005445 | |
| Drug | tesmilifene | 4.08e-05 | 21 | 215 | 4 | CID000108092 | |
| Drug | Dutasteride | 4.08e-05 | 21 | 215 | 4 | ctd:D000068538 | |
| Drug | chlordecone | 4.08e-05 | 67 | 215 | 6 | CID000000299 | |
| Drug | 2-cyclohexen-1-ol | 4.49e-05 | 8 | 215 | 3 | CID000013198 | |
| Drug | Cocaine | 4.49e-05 | 8 | 215 | 3 | DB00907 | |
| Drug | w 77 | 4.49e-05 | 8 | 215 | 3 | CID003086590 | |
| Drug | tXMP | 4.49e-05 | 8 | 215 | 3 | CID003081384 | |
| Drug | benzene dihydrodiol | 4.95e-05 | 22 | 215 | 4 | CID000000418 | |
| Drug | geldanamicin | ERBB2 HLA-DRA SLC7A11 PGR ABCB1 PTK2B KDR GNL1 ABCB5 LBP TGM2 TRAP1 ARNT | 5.90e-05 | 373 | 215 | 13 | CID000003460 |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 5.95e-05 | 23 | 215 | 4 | DB03461 | |
| Drug | Foscarnet | 6.69e-05 | 9 | 215 | 3 | ctd:D017245 | |
| Drug | So324 | 6.69e-05 | 9 | 215 | 3 | CID000462261 | |
| Drug | Mexiletine | 6.69e-05 | 9 | 215 | 3 | ctd:D008801 | |
| Drug | verapamil | ABCA3 ABCA12 BIRC6 RYR3 ABCB1 PTK2B SCN5A PKD1 SCN10A ABCB5 ABCC5 ACE2 SLC22A4 SLC22A5 ATP2B4 | 7.01e-05 | 490 | 215 | 15 | CID000002520 |
| Drug | Glycyrrhetinic Acid | 7.08e-05 | 24 | 215 | 4 | ctd:D006034 | |
| Drug | 9,10-phenanthrenequinone | 8.37e-05 | 25 | 215 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 8.37e-05 | 25 | 215 | 4 | ctd:D011280 | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 8.48e-05 | 190 | 215 | 9 | 6844_UP | |
| Drug | Hypochlorous Acid | ME1 SLC7A11 STXBP2 PAPOLA HPCAL1 TBCD API5 TRAP1 USO1 SLC20A1 MYO1F RPL35 MVD | 8.56e-05 | 387 | 215 | 13 | ctd:D006997 |
| Drug | AC1L1J6H | ABCB1 PCSK9 MAPK8IP1 TMEM176B ABCB5 ABCC5 MSH2 PPP1R3A LIPC MVD | 8.74e-05 | 236 | 215 | 10 | CID000004889 |
| Drug | diphenyltin oxide | 8.88e-05 | 2 | 215 | 2 | CID000075280 | |
| Drug | Hexylcaine | 8.88e-05 | 2 | 215 | 2 | DB00473 | |
| Drug | mesochlorin e6 monoethylenediamine | 8.88e-05 | 2 | 215 | 2 | CID005488855 | |
| Drug | alpha-methylcinnamic acid | 8.88e-05 | 2 | 215 | 2 | ctd:C510582 | |
| Drug | taxuspine C | 8.88e-05 | 2 | 215 | 2 | CID005321745 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 8.88e-05 | 2 | 215 | 2 | CID000283230 | |
| Drug | Ro44-5912 | 8.88e-05 | 2 | 215 | 2 | CID000197370 | |
| Drug | Riluzole | 8.88e-05 | 2 | 215 | 2 | DB00740 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 8.88e-05 | 2 | 215 | 2 | CID005281903 | |
| Drug | AC1L8LCS | 8.88e-05 | 2 | 215 | 2 | CID000383419 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 8.88e-05 | 2 | 215 | 2 | DB07768 | |
| Drug | sulfurmycin A | 8.88e-05 | 2 | 215 | 2 | CID000155836 | |
| Disease | Colorectal Carcinoma | ABCA3 ABCA12 CABLES1 ABCB1 PROM1 KDR DNAH8 AGTPBP1 CNTN4 DNAH3 DPYSL2 ABCB5 WRN ABCC5 GRID1 MSH2 TGFBR1 TGM2 ARNT EXO1 SNRNP200 | 4.64e-08 | 702 | 213 | 21 | C0009402 |
| Disease | Colorectal Neoplasms | ABCA3 ABCA12 CABLES1 ABCB1 PROM1 KDR ABCB5 ABCC5 GRID1 MSH2 TGFBR1 ARNT EXO1 | 1.28e-07 | 277 | 213 | 13 | C0009404 |
| Disease | Neoplasms, Hormone-Dependent | 3.71e-07 | 3 | 213 | 3 | C0027661 | |
| Disease | Intersex Conditions | 3.67e-06 | 5 | 213 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 3.67e-06 | 5 | 213 | 3 | C2930619 | |
| Disease | Hermaphroditism | 3.67e-06 | 5 | 213 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 3.67e-06 | 5 | 213 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 3.67e-06 | 5 | 213 | 3 | C0033804 | |
| Disease | Malignant neoplasm of breast | ERBB2 ABCA3 CEP85L PGR ABCB1 SORCS1 FASN NAA25 PIM1 UTP20 KDR DNAH9 SYT3 CBFB LEPR PPP1R3A TGM2 RIF1 TRMT2A EXO1 MACF1 HDLBP | 1.18e-05 | 1074 | 213 | 22 | C0006142 |
| Disease | Disorders of Sex Development | 1.27e-05 | 7 | 213 | 3 | C0036875 | |
| Disease | metabolite measurement | GCKR AKR1C2 STAB1 SORCS1 SLC44A5 BBOX1 PCSK9 WDFY4 SLC7A9 LIPC SLC22A4 SLC22A5 AKR1C3 ACMSD DPY19L2P2 | 1.54e-05 | 560 | 213 | 15 | EFO_0004725 |
| Disease | Endometrioma | 2.36e-05 | 161 | 213 | 8 | C0269102 | |
| Disease | Endometriosis | 2.36e-05 | 161 | 213 | 8 | C0014175 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.29e-05 | 10 | 213 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.29e-05 | 10 | 213 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | TYPE 2 DIABETES MELLITUS | 4.72e-05 | 28 | 213 | 4 | 125853 | |
| Disease | Type 2 diabetes mellitus | 4.72e-05 | 28 | 213 | 4 | cv:C0011860 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 5.19e-05 | 2 | 213 | 2 | C1839840 | |
| Disease | MEHMO syndrome (implicated_via_orthology) | 5.19e-05 | 2 | 213 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 5.19e-05 | 2 | 213 | 2 | cv:C1839840 | |
| Disease | 46,XY SEX REVERSAL 8 | 5.19e-05 | 2 | 213 | 2 | 614279 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 5.19e-05 | 2 | 213 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 7.78e-05 | 12 | 213 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | hexanoylcarnitine measurement | 7.78e-05 | 12 | 213 | 3 | EFO_0021040 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 8.82e-05 | 194 | 213 | 8 | EFO_0004265, EFO_0007908 | |
| Disease | homostachydrine measurement | 1.01e-04 | 13 | 213 | 3 | EFO_0021164 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.14e-04 | 150 | 213 | 7 | EFO_0004611, EFO_0020947 | |
| Disease | asthma (is_implicated_in) | 1.51e-04 | 157 | 213 | 7 | DOID:2841 (is_implicated_in) | |
| Disease | Alcoholic Intoxication, Chronic | 1.54e-04 | 268 | 213 | 9 | C0001973 | |
| Disease | Primary Erythermalgia | 1.55e-04 | 3 | 213 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.55e-04 | 3 | 213 | 2 | C1833661 | |
| Disease | epilepsy (implicated_via_orthology) | 1.90e-04 | 163 | 213 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Nodular glomerulosclerosis | 2.17e-04 | 41 | 213 | 4 | C0017667 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 2.43e-04 | 120 | 213 | 6 | EFO_0004611, EFO_0004639 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.54e-04 | 121 | 213 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.55e-04 | 171 | 213 | 7 | DOID:9352 (is_implicated_in) | |
| Disease | Diabetic Nephropathy | 2.86e-04 | 44 | 213 | 4 | C0011881 | |
| Disease | monocyte chemotactic protein-2 measurement | 3.08e-04 | 4 | 213 | 2 | EFO_0010789 | |
| Disease | acute myelomonocytic leukemia (is_implicated_in) | 3.08e-04 | 4 | 213 | 2 | DOID:0081082 (is_implicated_in) | |
| Disease | Brugada ECG Pattern | 3.08e-04 | 4 | 213 | 2 | C1721096 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) measurement | 3.08e-04 | 4 | 213 | 2 | EFO_0800411 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 3.30e-04 | 127 | 213 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 3.40e-04 | 46 | 213 | 4 | EFO_0005325, HP_0012735 | |
| Disease | Malignant Neoplasms | 3.44e-04 | 128 | 213 | 6 | C0006826 | |
| Disease | apolipoprotein B measurement | HBS1L HLA-DRA BBS1 GCKR ABCB1 PCSK9 AP1M2 ATXN1L LIPC SLC22A5 ACMSD CEACAM20 DNAH11 HDLBP | 3.56e-04 | 663 | 213 | 14 | EFO_0004615 |
| Disease | lipoprotein measurement, phospholipid measurement | 3.84e-04 | 85 | 213 | 5 | EFO_0004639, EFO_0004732 | |
| Disease | polyunsaturated fatty acid measurement | 3.90e-04 | 131 | 213 | 6 | EFO_0010733 | |
| Disease | fetal hemoglobin measurement | 4.48e-04 | 21 | 213 | 3 | EFO_0004576 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 4.69e-04 | 50 | 213 | 4 | EFO_0022334 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 4.69e-04 | 50 | 213 | 4 | EFO_0022247 | |
| Disease | lipid measurement, lipoprotein measurement | 5.00e-04 | 90 | 213 | 5 | EFO_0004529, EFO_0004732 | |
| Disease | eosinophil count | HBS1L HLA-DPA1 HLA-DRA ITGA6 DGKH GCKR SLC7A11 CABLES1 LAPTM5 PTK2B EPS15L1 NAA25 MDN1 DNAH3 MTERF1 ABCB5 ABCC5 PPP1R3A LIPC EXO1 SPIDR SNRNP200 HDLBP | 5.04e-04 | 1488 | 213 | 23 | EFO_0004842 |
| Disease | level of Phosphatidylcholine (15:0_18:1) in blood serum | 5.11e-04 | 5 | 213 | 2 | OBA_2045064 | |
| Disease | hyperinsulinism (implicated_via_orthology) | 5.11e-04 | 5 | 213 | 2 | DOID:2018 (implicated_via_orthology) | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 5.11e-04 | 5 | 213 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | leptin receptor measurement | 5.11e-04 | 5 | 213 | 2 | EFO_0004635 | |
| Disease | sleep apnea (is_marker_for) | 5.11e-04 | 5 | 213 | 2 | DOID:0050847 (is_marker_for) | |
| Disease | serum metabolite measurement | HLA-DPA1 GCKR SLC7A11 SLC44A5 BBOX1 PCSK9 CNTN4 DPYSL2 SLC7A9 LIPC SLC10A2 SLC22A4 DNAH17 SLC22A5 AKR1C3 NIPAL1 KCNIP4 | 5.41e-04 | 945 | 213 | 17 | EFO_0005653 |
| Disease | TPE interval measurement | 5.45e-04 | 52 | 213 | 4 | EFO_0004644 | |
| Disease | phospholipid measurement | 5.54e-04 | 140 | 213 | 6 | EFO_0004639 | |
| Disease | Degenerative polyarthritis | 5.81e-04 | 93 | 213 | 5 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 5.81e-04 | 93 | 213 | 5 | C0086743 | |
| Disease | Immunologic Deficiency Syndromes | 5.90e-04 | 23 | 213 | 3 | C0021051 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 5.97e-04 | 197 | 213 | 7 | EFO_0005680 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 6.71e-04 | 24 | 213 | 3 | OBA_2045136 | |
| Disease | Obesity | 7.55e-04 | 205 | 213 | 7 | C0028754 | |
| Disease | hypopituitarism (implicated_via_orthology) | 7.63e-04 | 6 | 213 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | Carditis | 7.63e-04 | 6 | 213 | 2 | C0869523 | |
| Disease | level of Phosphatidylcholine (16:0_18:1) in blood serum | 7.63e-04 | 6 | 213 | 2 | OBA_2045070 | |
| Disease | intercellular adhesion molecule 2 measurement | 7.63e-04 | 6 | 213 | 2 | EFO_0008163 | |
| Disease | cortolone glucuronide (1) measurement | 7.63e-04 | 6 | 213 | 2 | EFO_0800552 | |
| Disease | Coxsackievirus Infections | 7.63e-04 | 6 | 213 | 2 | C0010246 | |
| Disease | lipopolysaccharide-binding protein measurement | 7.63e-04 | 6 | 213 | 2 | EFO_0021894 | |
| Disease | Myocarditis | 7.63e-04 | 6 | 213 | 2 | C0027059 | |
| Disease | brain measurement, hippocampal volume | 7.63e-04 | 6 | 213 | 2 | EFO_0004464, EFO_0005035 | |
| Disease | low density lipoprotein particle size measurement | 8.26e-04 | 58 | 213 | 4 | EFO_0008593 | |
| Disease | complex trait | 8.33e-04 | 271 | 213 | 8 | EFO_0010578 | |
| Disease | Weight Gain | 8.83e-04 | 102 | 213 | 5 | C0043094 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 9.23e-04 | 103 | 213 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | cholesterol to total lipids in IDL percentage | 9.38e-04 | 60 | 213 | 4 | EFO_0022233 | |
| Disease | lipoprotein measurement | 1.01e-03 | 105 | 213 | 5 | EFO_0004732 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 1.06e-03 | 28 | 213 | 3 | OBA_2045139 | |
| Disease | 1-palmitoyl-GPE (16:0) measurement | 1.06e-03 | 7 | 213 | 2 | EFO_0800245 | |
| Disease | electrocardiography, PR interval | 1.06e-03 | 7 | 213 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Congenital Pain Insensitivity | 1.06e-03 | 7 | 213 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.06e-03 | 7 | 213 | 2 | C0020075 | |
| Disease | smoking status measurement, inflammatory bowel disease | 1.06e-03 | 7 | 213 | 2 | EFO_0003767, EFO_0006527 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 1.06e-03 | 7 | 213 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 1.17e-03 | 221 | 213 | 7 | C0011860 | |
| Disease | Child Development Disorders, Specific | 1.18e-03 | 29 | 213 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.18e-03 | 29 | 213 | 3 | C0085996 | |
| Disease | fibrinogen measurement | 1.19e-03 | 109 | 213 | 5 | EFO_0004623 | |
| Disease | diffuse plaque measurement | HBS1L AKR1C2 DNAH14 HPCAL1 SYK COL14A1 KDR HS3ST4 AGTPBP1 MTERF1 GRID1 MACF1 KCNIP4 DNAH11 | 1.30e-03 | 758 | 213 | 14 | EFO_0010699 |
| Disease | Developmental Disabilities | 1.30e-03 | 30 | 213 | 3 | C0008073 | |
| Disease | asthma, cardiovascular disease | 1.30e-03 | 30 | 213 | 3 | EFO_0000319, MONDO_0004979 | |
| Disease | Crohn's disease (is_implicated_in) | 1.30e-03 | 30 | 213 | 3 | DOID:8778 (is_implicated_in) | |
| Disease | free cholesterol measurement | 1.40e-03 | 113 | 213 | 5 | EFO_0008591 | |
| Disease | butyrylcarnitine measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0020010 | |
| Disease | acetylcarnitine measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0021038 | |
| Disease | hemoglobin A2 measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0005845 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTTKNEVVGRLILGA | 386 | Q9BT88 | |
| ILILVGQSRVLSKGV | 981 | O60241 | |
| VGLAIRSKIADGSVK | 61 | P17516 | |
| ALTGRILDLKTGTVK | 231 | P27540 | |
| QLRSLTEILKGGVLI | 141 | P04626 | |
| AGRVQLETIIKSLKS | 521 | Q9UBC2 | |
| GGTGITILIINLKKS | 141 | Q01362 | |
| NGSVLLSEIVGTIKL | 186 | Q9Y6Q5 | |
| VLVKIGLQSTRIGLK | 3381 | Q9NR09 | |
| ILRLTHVKTGGKISL | 131 | Q9UL15 | |
| IVKESGGKLTRRLVN | 321 | Q9NPI1 | |
| VGLAIRSKIADGSVK | 61 | P42330 | |
| GLNLRIKSGETVALV | 406 | Q2M3G0 | |
| KLSISIALIGGSRVV | 1486 | Q86UK0 | |
| LSKDGKILTILIVQR | 116 | Q6UY09 | |
| IDKIVTSLGLKIGAR | 316 | Q7Z2Z2 | |
| EGRTKAVGTITKLLQ | 561 | O00178 | |
| SQIKLSIKRLVTTGV | 66 | P07305 | |
| TLLKRVTLVKVGGEV | 411 | Q8IWV2 | |
| GIIVGTVLIIKSLRS | 236 | P20036 | |
| ALITKIGLQTEKVSR | 3136 | Q96DT5 | |
| RKLSIGIALIAGSKV | 671 | Q99758 | |
| LLTDVIGKDKVILGT | 276 | Q8TDX5 | |
| ATGVGKTLLVKRLQE | 31 | Q0P5N6 | |
| KILSGLKSLQTVSGR | 196 | Q9BZZ5 | |
| LVTRSGRLLGIITKK | 726 | P51793 | |
| AVLFITGIIILTSGK | 151 | Q96DB9 | |
| TVLINLGLIKVTEKG | 871 | Q8IWG1 | |
| IRTVSGIRGQIKKAL | 1061 | Q14692 | |
| RVSFLVTKGGSQILL | 101 | Q9UPW5 | |
| VLQGKLTRLAVQIGK | 351 | P23634 | |
| VKDRAGSIVLKVLIS | 71 | O15511 | |
| QRKLLFTGLVSGVVL | 1266 | Q149M9 | |
| LLLSATSGEKGVRIK | 506 | Q9NW13 | |
| GSLTKAKVLITVLDV | 326 | Q9Y5G6 | |
| LIIVGAIGVGKTSLL | 11 | Q96AH8 | |
| AVIKRLISVLNKSTG | 611 | Q9Y450 | |
| RIGIKKAITANISIG | 286 | P08183 | |
| VTKAGAILVVTKLLR | 496 | Q7L1V2 | |
| KKVSLLNIATRITGG | 661 | Q5JPF3 | |
| GIRKDAKGISIQTLR | 471 | Q8IYY4 | |
| IIKTILKVKSSGGRA | 221 | Q8NGQ6 | |
| VGIQGLVLALVKSVT | 611 | Q14667 | |
| VSVKGISISVNLLLG | 131 | P18428 | |
| SVKSEEVLRGLGKLI | 3461 | Q9NU22 | |
| IIIGVKKGGTRALLE | 141 | Q9Y662 | |
| SKGLIVKGRASLTQE | 336 | P48163 | |
| RIVSQIKTKGALGIS | 396 | Q9NRR6 | |
| TLIIFGKRTLSNGEV | 181 | Q6W5P4 | |
| RITSDRLLIKGGKIV | 11 | Q16555 | |
| LEISVRGVKIGVKAD | 611 | Q9UQF2 | |
| IVLIGSKTNGKFLIR | 181 | P43405 | |
| KGAIIQLATGELKRV | 471 | P0C7T5 | |
| QLRDISSIGLKTVIG | 101 | Q86VP6 | |
| RIGDTKSEIKILSIG | 46 | P50135 | |
| VSGTLIGLEFIRKSQ | 261 | Q8NBP7 | |
| TSVLTNTRVVKIGLG | 131 | Q9H339 | |
| VLTLKTVLGIVSRGE | 221 | Q8NH63 | |
| TNSRIIKIGLTIIGR | 146 | Q9H2C8 | |
| LIAIGGVKITSTLQV | 416 | Q8NEN9 | |
| TKLTVGSLGLGLIII | 31 | Q8IXQ8 | |
| VRVSQLLAVTGKKTT | 166 | Q13951 | |
| GARISIEGTVKLKTI | 101 | Q96JB1 | |
| IIALSVTSRGKLEQK | 86 | P37235 | |
| IKGLSILLRGTVQEK | 146 | Q6PIL6 | |
| GKLSKQTRTTLGALV | 1151 | Q6ZR08 | |
| ARGQILKILTGKIVV | 246 | Q9H9L3 | |
| KELGKRTGTVQVLKR | 2836 | O94854 | |
| SGLVLKTIRVKAGET | 446 | P11150 | |
| RVLILVVSAEKKLTG | 196 | P53602 | |
| GRREVFVAIKTLKVG | 656 | P54753 | |
| GVTSIKKRESGVLLT | 1081 | P48357 | |
| QGRKLLIIGTTSRKD | 636 | P46459 | |
| AKTKTLREGIIVTGK | 291 | Q96PP9 | |
| AKTKTLREGILVTGN | 276 | Q8N8V2 | |
| VGKSSLINGLVGRKV | 371 | P36915 | |
| LINGLVGRKVVSVSR | 376 | P36915 | |
| IIIGVKKGGTRALLE | 156 | Q9Y663 | |
| QIIKGTGIILELFTS | 56 | A8MYU2 | |
| AKAKVVIELLLSVSG | 826 | P23229 | |
| GTIILKFLTSKILGV | 436 | Q6NUT2 | |
| VKRILQGIKELGRST | 1201 | Q86XP1 | |
| RGKKVSVTLASTLGL | 2421 | Q9UPN3 | |
| LGKRTGTVQVLKRSG | 6711 | Q9UPN3 | |
| VLEEIKLISKTGGQR | 616 | Q9NZB8 | |
| KVSEGGLNVTLTIRL | 36 | P57721 | |
| KRIVVKLGSAVVTRG | 71 | P54886 | |
| VIVKNLSSGTRVVLK | 336 | Q9UG01 | |
| ILKVSNGCVSKILGR | 46 | O43316 | |
| LLGSTSIKGIIRVLN | 136 | Q16821 | |
| VAAGKKRVIVIGISV | 166 | Q14397 | |
| VGLVESKIRILVGSL | 391 | P51003 | |
| ELIKAIGLRQKGVVS | 851 | P06401 | |
| ATGSIQILIKTEKGL | 1606 | Q5VYJ5 | |
| LILKAIRGVVFVKGT | 926 | O15440 | |
| RVAKLLSIVALVGGV | 311 | Q7Z6L0 | |
| AIKTITILALGQVDG | 456 | Q9UP38 | |
| LFRIRSVIKQGGTKT | 426 | Q13467 | |
| LSFIKILLKRGGVRV | 16 | Q9HDB9 | |
| ILLKRGGVRVSTKNL | 21 | Q9HDB9 | |
| KALLSVGVSKRSNIV | 91 | P0CF75 | |
| KERVGTSKVLVLLSG | 231 | P49915 | |
| SELRIILVGKTGTGK | 21 | Q9UG22 | |
| RQSTGAVSLKEIIGL | 371 | Q8TDN4 | |
| LRAIKSVLVVAGSLK | 2021 | Q9UFH2 | |
| IVQLVRGKLSSGARL | 1321 | Q8TD57 | |
| IKLLLEAGTNRSVKT | 826 | Q8WZ74 | |
| RTGVSKIGILITDGK | 256 | Q05707 | |
| LQKELGLISGISIIV | 26 | P82251 | |
| TEIKRILSVKGLLVG | 971 | P01031 | |
| LSTLKKVGIVRLTGA | 141 | O75936 | |
| GIVILIFTGIRDRKK | 756 | Q9BYF1 | |
| IGKAKALTSQLRTIG | 186 | Q5SZL2 | |
| IIIGTIFIIKGLRKS | 231 | P01903 | |
| GGKTTVRRILEKALT | 1431 | Q0VDD8 | |
| GSRLQGLTLKVVTVL | 431 | Q9ULK0 | |
| RVAIILLKEGSKAIG | 351 | Q8NCS7 | |
| GNIKILITTDIVSRG | 516 | Q86TM3 | |
| KRKTLVLIGASGVGR | 281 | Q00013 | |
| AIKSVLVVAGSLKRG | 2046 | Q9NYC9 | |
| RVSAVKADLGKIVLT | 416 | Q2VIR3 | |
| KVIIGTKTILANGAL | 231 | P49770 | |
| KNVGLTLRKLIGSVD | 911 | Q14289 | |
| EGVVAVLLTKKSLAR | 226 | P49327 | |
| TTRGGGLIIKILKRT | 391 | Q8NFJ9 | |
| SNKGISDIIKVLVLR | 556 | Q8NFJ9 | |
| LLGAKVSETIRKGLI | 76 | Q8WUM9 | |
| LLGAKVGETIRKGII | 61 | Q08357 | |
| ILGKSVRIIFSTLGV | 221 | Q9H015 | |
| ILGKSVRIIFSTLGV | 221 | O76082 | |
| RNIAKLGKVSLISTG | 116 | Q08AI6 | |
| IIQRGGILITERKKA | 216 | P43246 | |
| IIALSVTSRGKLEQK | 86 | P61601 | |
| LIIGVKKGGTRALLE | 201 | Q9Y661 | |
| VSSVKGLGIAIKELI | 251 | Q6NVV3 | |
| GTIILKFLTSKILGV | 246 | Q6ZN68 | |
| LLKISGIILKTGESQ | 51 | Q9BXW9 | |
| LLRLLITKGAKVNGR | 616 | Q99549 | |
| VLVTSIKVNGSLGLE | 1466 | P98161 | |
| IVGRKIGKIRSSAFL | 1536 | Q5THK1 | |
| IISTILKIASVEGRK | 231 | P30954 | |
| GAVTIQGVLRRKTLL | 456 | Q86X27 | |
| KIILKIGSIAGAILI | 191 | Q12908 | |
| RSLIRKSGLVVLGQE | 246 | Q5VVY1 | |
| GTRGVVALQTLRKLV | 451 | Q9NP80 | |
| VLLKKVSSGFSGVIR | 91 | P11309 | |
| GRLTVTIIKASNLKA | 446 | Q9BQG1 | |
| GKLRIAKTQGRTEVS | 41 | P13984 | |
| LTLRVGAGQDKIVIS | 761 | Q5VWG9 | |
| ILSQGSKIQTRVGLL | 481 | O60763 | |
| RAQVSKELGILSKIS | 1326 | O75691 | |
| GRTGKIRVQSLKIGL | 2946 | P46939 | |
| LIKKGVLITAVVEVG | 166 | Q8WVZ7 | |
| VGKLLIRKSGRVQLL | 326 | P05423 | |
| IRKSGRVQLLLGKVT | 331 | P05423 | |
| IGLALARKVKRVIGV | 446 | Q8IZ69 | |
| VTGGAASKLSKIRVV | 36 | P42766 | |
| VGISLVLGTLISILK | 376 | Q86VL8 | |
| TLRVKAKKGVTLLGT | 331 | Q6IEE7 | |
| ISLSLLIGVVKNREK | 76 | Q13571 | |
| LIRAKNIKTIGDLST | 2321 | Q5UIP0 | |
| LGTIISRTAKLIVAG | 136 | Q92859 | |
| TTVVAGIKRVLNSIG | 376 | O43490 | |
| ITGVKTVLISRLKQA | 41 | Q9NWH9 | |
| SVISGLKTIVGALIQ | 231 | Q14524 | |
| NTSVVVALLRKGAKL | 1256 | Q9C0D5 | |
| SGITRVEKAKIGLIQ | 236 | P50991 | |
| LVRVKKSAATLGIAI | 816 | Q9P202 | |
| RGKLGKVALIQLCVS | 91 | Q14191 | |
| LQKTTGKRGIVISRS | 1471 | P14410 | |
| LVTVLGNLGLITLIK | 36 | Q8NH85 | |
| IIIKVKSSGIRVGSS | 231 | P30874 | |
| TVGVERVISTKGLNL | 396 | Q9UQ84 | |
| SKLLKGVISEQGLRE | 581 | O60287 | |
| VRGKGLLNAIVIKET | 371 | P04181 | |
| LKVIVSLVSLGVGLR | 216 | Q3YBM2 | |
| VQKILAIGTRTGAIR | 81 | Q9Y2K9 | |
| IARTIVLQESIGKGR | 201 | P36897 | |
| VGLAIRSKIADGSVK | 61 | Q04828 | |
| VGLAIRSKIADGSVK | 61 | P52895 | |
| KVGAVVLISGAVLLL | 41 | O75829 | |
| KITLLREISLKTGIQ | 926 | O75153 | |
| VVRSGGLVKTRSKNI | 126 | Q9Y2G3 | |
| GLVKTRSKNIRVGDI | 131 | Q9Y2G3 | |
| ILGSVLKGQVATVIK | 386 | O95436 | |
| TAGTLLQKLRAKGIR | 281 | Q9Y6X2 | |
| INRSLIVGLKISTKS | 416 | P21980 | |
| IVGLKISTKSVGRDE | 421 | P21980 | |
| VITGLAARKTTGIRK | 101 | Q96QD9 | |
| KRKVTLLRGVSIIIG | 41 | Q9UPY5 | |
| GLRVSVGLLLVKSVQ | 76 | Q96DA0 | |
| LGKQVRSLKALVITI | 136 | Q8N511 | |
| GTLLLSRLIKISGTQ | 166 | Q9Y2W6 | |
| IIGGKATGVIVKTIL | 271 | O75970 | |
| VKTIARGLVGGLKNT | 271 | Q0VAA5 | |
| LSGRKSGVLTVKILE | 291 | Q14159 | |
| VIQGLVKDRSIFTGL | 326 | Q8IWA0 | |
| IQTGKGEAIRIRSIL | 2306 | Q15413 | |
| IVTVSLLELGVAKKG | 736 | Q9Y5Y9 | |
| SKVLIKEGGVQLLLT | 96 | Q16181 | |
| VLLIFVSGKVVLTGA | 301 | P20226 | |
| VSGKVVLTGAKVRAE | 306 | P20226 | |
| LKAVVGEKILSGVIR | 6 | Q15833 | |
| LALATEGGVLKKVIR | 16 | P24821 | |
| TVDGTKTQTRLVKLI | 1756 | P24821 | |
| VVTLLKGSVRNAVVL | 551 | Q6ZS81 | |
| LKTAIEKITQRGGLS | 356 | Q6UXI7 | |
| ISTLKSRIKELVNAG | 356 | Q99551 | |
| TGKKANRGTRIALVV | 11 | P78562 | |
| GVLLEKVAATLKTLV | 341 | O60809 | |
| LGGGVVTIERSKSKI | 56 | P35268 | |
| HGQLTVEKLISKGRI | 581 | Q9NY15 | |
| GTKQLQVLRFLGISI | 216 | O95859 | |
| LNAKTKVRGLIEIIS | 1836 | O75643 | |
| GVRTGTKIIIHLKSD | 246 | Q12931 | |
| KVIIGFVLKRSLTNV | 51 | Q6ZRF7 | |
| KAISVVSRLKVIVGA | 231 | Q9UI33 | |
| VIVGALLRSVKKLVN | 241 | Q9UI33 | |
| VLLIRVVTSSIKVQG | 411 | Q6NXT6 | |
| TLLRKLGVKLVQRLG | 291 | Q9BTW9 | |
| LLKLIEIGVQTGSTA | 1326 | P35968 | |
| KIIGRKGAVITQIRL | 1066 | Q00341 | |
| IGRVIKKSLVEATGV | 1001 | Q8WY21 | |
| LLTLEGRTGTNEKKI | 206 | Q9ULD5 | |
| TVVTGGEVKKLKRLT | 66 | A0A087WT01 | |
| LVLVGLIRSSKGILV | 226 | Q9C0H2 | |
| RVSAVKADLGKIVLT | 416 | P41091 | |
| LAVLKVGGRTLTVSV | 901 | O00160 | |
| SKLGLLQVTGVTRVT | 81 | Q9H009 | |
| KLGLQQVTGVTRVTI | 81 | Q9BZK3 | |
| IRGKLGEKLTSEIQS | 216 | Q14CX7 | |
| TKISKLIGSRTVLQV | 141 | Q5VVJ2 |